Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
APOA2,Apolipoprotein A-II,Lifestyle factors,X1050.Time spend outdoors in summer,45676,0.0233518781666716,0.0258399925032975,-0.0272945071397915,0.0739982634731346,0.366158793624957
APOA2,Apolipoprotein A-II,Lifestyle factors,X1060.Time spent outdoors in winter,42425,0.0282870528102118,0.0294567876291727,-0.0294482509429667,0.0860223565633903,0.336921887211619
APOA2,Apolipoprotein A-II,Physical activities,X1070.Time spent watching television (TV),46741,0.0806734926329325,0.0256346869390133,0.0304295062324665,0.130917479033398,0.00165141607604064
APOA2,Apolipoprotein A-II,Physical activities,X1080.Time spent using computer,42406,-0.0689322894969076,0.0271827878183006,-0.122210553620777,-0.0156540253730385,0.0112246514767733
APOA2,Apolipoprotein A-II,Physical activities,X1090.Time spent driving,41429,-0.10992538051195,0.0288384873111323,-0.166448815641769,-0.0534019453821303,0.000138451920502468
APOA2,Apolipoprotein A-II,Lifestyle factors,X1160.Sleep duration,48284,-0.0588305434129705,0.0241042755228421,-0.106074923437741,-0.0115861633882,0.0146671648333792
APOA2,Apolipoprotein A-II,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32723,-0.0234947666999062,0.0168417963133181,-0.0565046874740097,0.00951515407419729,0.163042544715468
APOA2,Apolipoprotein A-II,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32723,-0.0260992902784785,0.016559388474401,-0.0585556916883045,0.00635711113134753,0.115037919261902
APOA2,Apolipoprotein A-II,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32723,-0.013364186758818,0.0193771541528163,-0.051343408898338,0.024615035380702,0.490408598365693
APOA2,Apolipoprotein A-II,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32723,0.00881966059664136,0.0200441776188423,-0.0304669275362895,0.0481062487295722,0.659939799030366
APOA2,Apolipoprotein A-II,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32723,-0.0159784829601015,0.0205890375853023,-0.056332996627294,0.024376030707091,0.437729839191365
APOA2,Apolipoprotein A-II,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32723,-0.0196102999815231,0.0393267928015471,-0.0966908138725554,0.0574702139095091,0.618038443182818
APOA2,Apolipoprotein A-II,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32723,-0.0345610155219173,0.0400408829251896,-0.113041146055289,0.0439191150114543,0.388082098250677
APOA2,Apolipoprotein A-II,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32723,0.0421571823595607,0.0287854044953889,-0.0142622104514016,0.098576575170523,0.143083769786158
APOA2,Apolipoprotein A-II,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32723,0.0539685735422423,0.021420036985549,0.0119853010505664,0.0959518460339183,0.0117683686107684
APOA2,Apolipoprotein A-II,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32723,-0.0135304089140383,0.0150991809658452,-0.043124803607095,0.0160639857790184,0.370222532475056
APOA2,Apolipoprotein A-II,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32723,0.00621474443781709,0.0212480565173208,-0.0354314463361317,0.0478609352117659,0.769922435058013
APOA2,Apolipoprotein A-II,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32723,-0.00965830526395089,0.0122054023210841,-0.0335808938132757,0.0142642832853739,0.428781978636305
APOA2,Apolipoprotein A-II,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32723,-0.0248943400685707,0.0156275821532545,-0.0555244010889495,0.00573572095180819,0.111201568716412
APOA2,Apolipoprotein A-II,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32723,-0.0341686173154461,0.0236857298900586,-0.080592647899961,0.0122554132690689,0.149173478639849
APOA2,Apolipoprotein A-II,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32723,-0.0403978776035512,0.0220098418636333,-0.0835371676562724,0.00274141244916999,0.0664731109642225
APOA2,Apolipoprotein A-II,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32723,-0.0273933029689553,0.0271723753405308,-0.0806511586363956,0.025864552698485,0.313419292249206
APOA2,Apolipoprotein A-II,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32723,0.00661283220989287,0.0262491663826415,-0.0448355339000844,0.0580611983198701,0.80110455372152
APOA2,Apolipoprotein A-II,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32723,0.011833338911986,0.0174077428001683,-0.0222858369763439,0.045952514800316,0.496665036057759
APOA2,Apolipoprotein A-II,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32723,-0.00595570516737892,0.0163981410284005,-0.0380960615830439,0.0261846512482861,0.716468688622725
APOA2,Apolipoprotein A-II,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32723,0.0211859346649607,0.0203009764567645,-0.0186039791902977,0.0609758485202192,0.29670270347441
APOA2,Apolipoprotein A-II,Health and medical history,X120040.Fatigue severity over the past week,32732,-0.0353059219157674,0.0418423336933393,-0.117316895954712,0.0467050521231776,0.398812468937811
APOA2,Apolipoprotein A-II,Health and medical history,X120041.Waking unrefreshed severity over the past week,32734,-0.0307860253123144,0.0412330521886873,-0.111602807602141,0.0500307569775126,0.455303913709247
APOA2,Apolipoprotein A-II,Health and medical history,X120042.Cognitive symptoms severity over the past week,32732,-0.136572081436113,0.0456046821855946,-0.225957258519879,-0.0471869043523478,0.0027547830085894
APOA2,Apolipoprotein A-II,Health and medical history,X120098.Mobility problems today,32736,-0.052882153932501,0.0503542752724401,-0.151576533466484,0.0458122256014816,0.293653913080545
APOA2,Apolipoprotein A-II,Health and medical history,X120099.Self-care problems today,32736,-0.0189261077229739,0.0766877020553817,-0.169234003751522,0.131381788305574,0.805072929815088
APOA2,Apolipoprotein A-II,Health and medical history,X120100.Problems doing usual activities,32736,-0.0142116184819247,0.0474003794664534,-0.107116362236173,0.078693125272324,0.764320891255902
APOA2,Apolipoprotein A-II,Health and medical history,X120101.Pain or discomfort today,32736,0.0234303349359526,0.041698824985539,-0.0582993620357038,0.105160031907609,0.574202183369916
APOA2,Apolipoprotein A-II,Health and medical history,X120102.Anxiety or depression today,32736,-0.0577245635658496,0.0493820059406768,-0.154513295209576,0.0390641680778769,0.242459522518609
APOA2,Apolipoprotein A-II,Health and medical history,X120103.Scale to indicate how health is today,32703,8.98962083930308e-05,0.00523719189317613,-0.0101749999022322,0.0103547923190183,0.986305400279443
APOA2,Apolipoprotein A-II,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32719,-0.0682463138329699,0.049584555093234,-0.165432041815708,0.0289394141497686,0.168744278622378
APOA2,Apolipoprotein A-II,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32706,-0.0588468945885801,0.050757827860442,-0.158332237195046,0.0406384480178863,0.246338371965057
APOA2,Apolipoprotein A-II,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32725,-0.0147007474266818,0.0412790605516165,-0.0956077061078501,0.0662062112544864,0.721751042227317
APOA2,Apolipoprotein A-II,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32728,-0.0718157502613516,0.0423569443813011,-0.154835361248702,0.0112038607259985,0.0900177308962518
APOA2,Apolipoprotein A-II,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32723,-0.0690437990321564,0.051609122853591,-0.170197679825195,0.0321100817608819,0.180988933364157
APOA2,Apolipoprotein A-II,Health and medical history,X120109.Feeling bad about self over the last two weeks,32701,-0.0276809662696159,0.0524753409741326,-0.130532634578916,0.075170702039684,0.597856694239558
APOA2,Apolipoprotein A-II,Health and medical history,X120110.Trouble concentrating over the last two weeks,32728,-0.0977083774824228,0.0529040628468717,-0.201400340662291,0.00598358569744573,0.0647953081631813
APOA2,Apolipoprotein A-II,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32717,0.116706584076244,0.0781978365781816,-0.0365611756169921,0.26997434376948,0.135616094398545
APOA2,Apolipoprotein A-II,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32670,-0.061762479911031,0.103288813146712,-0.264208553678587,0.140683593856525,0.54988263537585
APOA2,Apolipoprotein A-II,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30207,-0.0276023895525353,0.0547441780192053,-0.134900978470178,0.0796961993651071,0.61413353457648
APOA2,Apolipoprotein A-II,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45557,-0.0589833536967313,0.056485193130289,-0.169694332232098,0.0517276248386351,0.296392094702256
APOA2,Apolipoprotein A-II,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,44390,0.00823408026591545,0.0346796724192277,-0.0597380776757708,0.0762062382076017,0.812323672053999
APOA2,Apolipoprotein A-II,Diet and food preferences,X1289.Cooked vegetable intake,47376,-0.0526659819543585,0.0249263975976027,-0.10152172124566,-0.00381024266305727,0.0346232836177147
APOA2,Apolipoprotein A-II,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46921,-0.012287697640203,0.0266326886750729,-0.064487767443346,0.03991237216294,0.644532834635874
APOA2,Apolipoprotein A-II,Diet and food preferences,X1309.Fresh fruit intake,47378,-0.00867180586729017,0.0263901912237315,-0.060396580665804,0.0430529689312236,0.742461288082929
APOA2,Apolipoprotein A-II,Diet and food preferences,X1319.Dried fruit intake,46048,-0.0458561175769883,0.0279434367514358,-0.100625253609803,0.0089130184558259,0.100804622553856
APOA2,Apolipoprotein A-II,Health and medical history,X134.Number of self-reported cancers,48485,0.0207512811658972,0.0546134145203308,-0.0862910112939512,0.127793573625746,0.703973380545927
APOA2,Apolipoprotein A-II,Health and medical history,X135.Number of self-reported non-cancer illnesses,48485,0.128099498902232,0.024313640260541,0.080444763991572,0.175754233812893,1.38603637424278e-07
APOA2,Apolipoprotein A-II,Health and medical history,"X136.Number of operations, self-reported",48485,0.0707229982750832,0.0241984074872314,0.0232941196001096,0.118151876950057,0.00347404040244794
APOA2,Apolipoprotein A-II,Health and medical history,X137.Number of treatments or medications taken,48485,0.181618652508567,0.0241691986024752,0.134247023247716,0.228990281769419,5.90874475953164e-14
APOA2,Apolipoprotein A-II,Diet and food preferences,X1438.Bread intake,47727,-0.0134613070874308,0.00333471834816782,-0.0199973550498397,-0.00692525912502184,5.43739627657033e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X1458.Cereal intake,47039,-0.135672293459049,0.0250056262072916,-0.18468332082534,-0.0866612660927573,5.83155714853913e-08
APOA2,Apolipoprotein A-II,Diet and food preferences,X1488.Tea intake,47520,0.00631235100103551,0.00316290004000582,0.000113066922624103,0.0125116350794469,0.0459728180642108
APOA2,Apolipoprotein A-II,Diet and food preferences,X1498.Coffee intake,46486,-0.0619249559008826,0.0251514140602773,-0.111221727459026,-0.0126281843427391,0.0138205366635931
APOA2,Apolipoprotein A-II,Diet and food preferences,X1528.Water intake,46755,0.0932448099995585,0.0257060442647413,0.0428609632406655,0.143628656758452,0.000286967597132371
APOA2,Apolipoprotein A-II,Lifestyle factors,X1568.Average weekly red wine intake,40528,-0.0340032683726606,0.0295075499997195,-0.0918380663721109,0.0238315296267896,0.249190421782261
APOA2,Apolipoprotein A-II,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,40522,0.101941598150188,0.0304531060548933,0.0422535102825976,0.161629686017779,0.000817261666326372
APOA2,Apolipoprotein A-II,Lifestyle factors,X1588.Average weekly beer plus cider intake,40565,0.0235986610653425,0.0331298276448568,-0.0413358011185767,0.0885331232492618,0.476283650061533
APOA2,Apolipoprotein A-II,Lifestyle factors,X1598.Average weekly spirits intake,40501,0.0860900056209515,0.033171035115703,0.0210747767941737,0.151105234447729,0.00945812455529471
APOA2,Apolipoprotein A-II,Lifestyle factors,X1608.Average weekly fortified wine intake,40557,0.125828823235111,0.0604622178351988,0.00732287627812131,0.244334770192101,0.0374385917961326
APOA2,Apolipoprotein A-II,Lifestyle factors,X1737.Childhood sunburn occasions,42772,0.030346649306822,0.029092103751538,-0.0266738740461924,0.0873671726598364,0.296904556184826
APOA2,Apolipoprotein A-II,Health and medical history,X1807.Father's age at death,38610,-0.00285973797134418,0.00448326899022593,-0.011646945192187,0.00592746924949864,0.523568909585779
APOA2,Apolipoprotein A-II,Health and medical history,X1845.Mother's age,37860,0.0061509452962591,0.00674452755335083,-0.00706832870830852,0.0193702193008267,0.361789402970915
APOA2,Apolipoprotein A-II,Health and medical history,X1873.Number of full brothers,48042,0.0187263188770753,0.0242281146879091,-0.0287607859112266,0.0662134236653772,0.439579127410271
APOA2,Apolipoprotein A-II,Health and medical history,X1883.Number of full sisters,48043,-0.0634625193892771,0.0242546242699208,-0.111001582958322,-0.0159234558202323,0.00888884332822353
APOA2,Apolipoprotein A-II,Physical measures,X20015.Sitting height,48276,-0.0131420782554113,0.00422196696078882,-0.0214171334985574,-0.0048670230122652,0.00185544556288353
APOA2,Apolipoprotein A-II,Cognitive function,X20016.Fluid intelligence score,31702,0.0370498887563923,0.0402827590656761,-0.0419043190123329,0.116004096525117,0.357734071947559
APOA2,Apolipoprotein A-II,Cognitive function,X20018.Prospective memory result,32009,-0.0177365286857162,0.0574103288701099,-0.130260773271132,0.0947877158996993,0.757372660043544
APOA2,Apolipoprotein A-II,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31627,0.00488862004570091,0.00592146783625751,-0.0067174569133638,0.0164946970047656,0.409070171866254
APOA2,Apolipoprotein A-II,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31635,-0.00465820276224873,0.00587443583808655,-0.0161720970048984,0.00685569148040091,0.427824320408056
APOA2,Apolipoprotein A-II,Cognitive function,X20023.Mean time to correctly identify matches,48206,0.0109453099398344,0.00335655135136369,0.00436646929116159,0.0175241505885072,0.00111219817185882
APOA2,Apolipoprotein A-II,Health and medical history,X20107#1.Illnesses of father_Heart disease,45633,-0.000702176647495465,0.00728147626824919,-0.0149738701332639,0.0135695168382729,0.92317734836114
APOA2,Apolipoprotein A-II,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45252,0.0129442166297791,0.0166156442942867,-0.0196224461870229,0.0455108794465811,0.435966007239206
APOA2,Apolipoprotein A-II,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45224,0.0113325247069079,0.0221518507432925,-0.0320851027499455,0.0547501521637612,0.608947716548684
APOA2,Apolipoprotein A-II,Health and medical history,X20107#12.Illnesses of father_Severe depression,45254,-0.015992033302436,0.0168608841158588,-0.0490393661695194,0.0170552995646473,0.342901236930336
APOA2,Apolipoprotein A-II,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45255,-0.0288471971952841,0.0123614013122553,-0.0530755437673044,-0.00461885062326368,0.0196232129740781
APOA2,Apolipoprotein A-II,Health and medical history,X20107#2.Illnesses of father_Stroke,45394,0.00349588440867697,0.00955960820130867,-0.015240947665888,0.022232716483242,0.714597558604593
APOA2,Apolipoprotein A-II,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45342,0.0109693745955542,0.0124560748807729,-0.0134445321707607,0.0353832813618691,0.378520083887497
APOA2,Apolipoprotein A-II,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45255,-0.0102011855428221,0.0150546101405375,-0.0397082214182755,0.0193058503326314,0.498025018300715
APOA2,Apolipoprotein A-II,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45374,0.00274225103722557,0.0118004181972399,-0.0203865686293645,0.0258710707038157,0.816240494417804
APOA2,Apolipoprotein A-II,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45494,0.00165377387720529,0.00754756671391755,-0.0131394568820731,0.0164470046364837,0.826563689671515
APOA2,Apolipoprotein A-II,Health and medical history,X20107#9.Illnesses of father_Diabetes,45365,-0.0232167995916696,0.0102293570988568,-0.043266339505429,-0.00316725967791024,0.0232402314937336
APOA2,Apolipoprotein A-II,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46556,-0.0123793119748392,0.00868682100091507,-0.0294054811366327,0.00464685718695436,0.154151251925299
APOA2,Apolipoprotein A-II,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46446,0.0210768906026153,0.0141154672154806,-0.00658942513972667,0.0487432063449572,0.135404836584136
APOA2,Apolipoprotein A-II,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46397,-0.0410711361765015,0.0301928171207787,-0.100249057733228,0.0181067853802247,0.173750216144528
APOA2,Apolipoprotein A-II,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46439,0.00991587625471353,0.012694716201469,-0.0149657675001658,0.0347975200095929,0.434750322629576
APOA2,Apolipoprotein A-II,Health and medical history,X20110#2.Illnesses of mother_Stroke,46500,0.00915725447003106,0.010366629584154,-0.0111613395149108,0.029475848454973,0.377062191510977
APOA2,Apolipoprotein A-II,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46442,0.02562933315224,0.0168467274106999,-0.00739025257273186,0.0586489188772118,0.128192515789349
APOA2,Apolipoprotein A-II,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46419,0.0305515154455771,0.0158703194806184,-0.000554310736435023,0.0616573416275892,0.054232848246628
APOA2,Apolipoprotein A-II,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46451,0.0194194255781369,0.0120917053796584,-0.00428031696599361,0.0431191681222674,0.108285220266675
APOA2,Apolipoprotein A-II,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46457,0.0239445558498069,0.014203419896629,-0.00389414714758591,0.0517832588471997,0.0918422927535608
APOA2,Apolipoprotein A-II,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46650,-0.00130853496681406,0.00683956264418717,-0.0147140777494209,0.0120970078157928,0.848277760644104
APOA2,Apolipoprotein A-II,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46504,-0.0288838629269538,0.0105891743368535,-0.0496386446271867,-0.00812908122672103,0.00638308932588856
APOA2,Apolipoprotein A-II,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,44053,-0.001025345010015,0.0139815200786517,-0.0284291243641723,0.0263784343441423,0.94153968454593
APOA2,Apolipoprotein A-II,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43955,-0.070575781205762,0.0800258771720733,-0.227426500463026,0.0862749380515016,0.377834947147389
APOA2,Apolipoprotein A-II,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43954,-0.0728057313667993,0.0678343595426937,-0.205761076070479,0.0601496133368803,0.283155287270115
APOA2,Apolipoprotein A-II,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,44032,0.0198862602802461,0.0128369350562174,-0.00527413242993995,0.0450466529904322,0.12136280740915
APOA2,Apolipoprotein A-II,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43958,0.0428349115538442,0.0439128132494881,-0.0432342024151526,0.128904025522841,0.329347049936701
APOA2,Apolipoprotein A-II,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43973,0.0394392187164799,0.0240911628914448,-0.00777946055075183,0.0866578979837116,0.10162889841046
APOA2,Apolipoprotein A-II,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43958,-0.00738367902525105,0.0316094169850796,-0.0693381363160071,0.054570778265505,0.81530480355728
APOA2,Apolipoprotein A-II,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43970,0.0328534591605836,0.0287895839865665,-0.0235741254530867,0.0892810437742539,0.253817838615859
APOA2,Apolipoprotein A-II,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43971,0.00655385962711288,0.019156674378645,-0.0309932221550313,0.044100941409257,0.732265018608614
APOA2,Apolipoprotein A-II,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43976,-0.00447925241680354,0.025420738557809,-0.0543038999901092,0.0453453951565021,0.860134939150754
APOA2,Apolipoprotein A-II,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,44134,-0.00521977336476586,0.0089965696285696,-0.0228530498367623,0.0124135031072306,0.561788924804195
APOA2,Apolipoprotein A-II,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,44039,-0.00292104722911487,0.0131385628634204,-0.0286726304414189,0.0228305359831891,0.824062179714271
APOA2,Apolipoprotein A-II,Mental health,X20127.Neuroticism score,43585,0.0274139727917143,0.0252188277779956,-0.022014929653157,0.0768428752365857,0.277030701248429
APOA2,Apolipoprotein A-II,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,31702,0.0776020131038933,0.0409520771367503,-0.00266405808413729,0.157868084291924,0.0581362302792275
APOA2,Apolipoprotein A-II,Lifestyle factors,X20161.Pack years of smoking,30750,0.000742305401725474,0.00695892928057742,-0.0128971959882063,0.0143818067916572,0.915054297513144
APOA2,Apolipoprotein A-II,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30750,0.000488520532581579,0.00650317887317395,-0.0122577100588394,0.0132347511240025,0.940121203601452
APOA2,Apolipoprotein A-II,Cognitive function,X20191.Fluid intelligence score,30186,-0.017878542448431,0.0467542082853413,-0.1095167906877,0.073759705790838,0.702181792918708
APOA2,Apolipoprotein A-II,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30186,-0.0185943570966747,0.0476816831331033,-0.112050456037557,0.0748617418442078,0.696572952721423
APOA2,Apolipoprotein A-II,Cognitive function,X20240.Maximum digits remembered correctly,29627,0.0870980835746252,0.0493269722861116,-0.00958278210615349,0.183778949255404,0.0774942423938638
APOA2,Apolipoprotein A-II,Physical measures,X20255.Spirometry QC measure,42159,-0.0177898062843372,0.0324199641197722,-0.0813329359590907,0.0457533233904162,0.583197462344821
APOA2,Apolipoprotein A-II,Eye measures,X20261.avMSE,29234,0.000889021892842765,0.00733593096885696,-0.0134894028061169,0.0152674465918024,0.903547189505825
APOA2,Apolipoprotein A-II,Eye measures,X20262.Myopia diagnosis,29234,-0.0182710826578354,0.0588694877321886,-0.133655278612925,0.0971131132972542,0.756294745951925
APOA2,Apolipoprotein A-II,NMR metabolomics,X20280.Glucose-lactate,37413,-0.0124467262382343,0.0044140073915241,-0.0210981807256216,-0.00379527175084709,0.00481196594020941
APOA2,Apolipoprotein A-II,NMR metabolomics,X20281.Spectrometer-corrected alanine,37441,0.00224444932084167,0.00436964894887617,-0.00632006261895563,0.010808961260639,0.607508409975328
APOA2,Apolipoprotein A-II,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31511,0.00480170464364545,0.0206910036572963,-0.0357526625246554,0.0453560718119463,0.816491975661415
APOA2,Apolipoprotein A-II,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31509,-0.0590926831486446,0.0418038876651948,-0.141028302972426,0.0228429366751372,0.157529158998183
APOA2,Apolipoprotein A-II,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31509,0.0231824039253224,0.0465530246482554,-0.0680615243852582,0.114426332235903,0.618513534793052
APOA2,Apolipoprotein A-II,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31509,0.000470868632458878,0.0200230461612249,-0.038774301843542,0.0397160391084597,0.981239023209312
APOA2,Apolipoprotein A-II,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31509,0.0189897773120494,0.0317268647898587,-0.0431948776760737,0.0811744323001725,0.54949782823845
APOA2,Apolipoprotein A-II,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31513,-0.0665010724373559,0.0411527645899905,-0.147160491033737,0.0141583461590255,0.106144963701242
APOA2,Apolipoprotein A-II,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31513,-0.0543239197364316,0.0276989124588224,-0.108613788155724,-3.40513171396412e-05,0.0498884819554945
APOA2,Apolipoprotein A-II,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31513,-0.0822292609534325,0.030044028546796,-0.141115556905153,-0.0233429650017123,0.00621532792761842
APOA2,Apolipoprotein A-II,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31513,-0.025534377404226,0.0466752649279454,-0.117017896662999,0.0659491418545469,0.584350416586393
APOA2,Apolipoprotein A-II,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31513,0.0172092439672282,0.0528384325712543,-0.0863540838724303,0.120772571806887,0.744663592729188
APOA2,Apolipoprotein A-II,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31513,-0.0449844172731428,0.031244921569411,-0.106224463549188,0.0162556290029028,0.149983197719171
APOA2,Apolipoprotein A-II,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31513,-0.0179999334717482,0.0528369945759527,-0.121560442840615,0.0855605758971192,0.733362024565966
APOA2,Apolipoprotein A-II,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31513,-0.0209799414138323,0.0395927457543836,-0.0985817230924242,0.0566218402647595,0.596201096298348
APOA2,Apolipoprotein A-II,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31516,-0.013609592695892,0.0540478812267603,-0.119543439900342,0.0923242545085582,0.80119760775723
APOA2,Apolipoprotein A-II,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31516,-0.0057601413471681,0.0269377675174695,-0.0585581656814084,0.0470378829870722,0.830684208408942
APOA2,Apolipoprotein A-II,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31516,-0.0190365012551734,0.0365691595225133,-0.0907120539192995,0.0526390514089527,0.602687238729747
APOA2,Apolipoprotein A-II,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31516,0.0241364308400203,0.0605810638675909,-0.0946024543404578,0.142875316020498,0.690335093270591
APOA2,Apolipoprotein A-II,Diet and food preferences,X20600.Liking for adding salt to foods,33475,0.0560797029088024,0.0370973171491217,-0.0166310387034761,0.128790444521081,0.130645230082385
APOA2,Apolipoprotein A-II,Diet and food preferences,X20601.Liking for aniseed,33475,0.0652417777636445,0.0369550553011727,-0.00719013062665393,0.137673686153943,0.0775223155830759
APOA2,Apolipoprotein A-II,Diet and food preferences,X20602.Liking for apple juice,33475,-0.0940633511239849,0.0370643099353488,-0.166709398597269,-0.0214173036507013,0.0111695087912068
APOA2,Apolipoprotein A-II,Diet and food preferences,X20603.Liking for apples,33475,-0.0259322992636084,0.0380379913088192,-0.100486762228894,0.0486221637016772,0.495415165887985
APOA2,Apolipoprotein A-II,Diet and food preferences,X20604.Liking for asparagus,33475,0.0874337927391234,0.0375054112558193,0.0139231866777176,0.160944398800529,0.01976173870125
APOA2,Apolipoprotein A-II,Diet and food preferences,X20605.Liking for aubergine,33475,0.052643400922835,0.0369123709300791,-0.0197048461001201,0.12499164794579,0.153851110134977
APOA2,Apolipoprotein A-II,Diet and food preferences,X20606.Liking for avocados,33475,0.0916396326273192,0.0374823683877503,0.0181741905873286,0.16510507466731,0.0145081538929606
APOA2,Apolipoprotein A-II,Diet and food preferences,X20607.Liking for bacon,33475,-0.106103969449876,0.0373509970340118,-0.179311923636539,-0.0328960152632129,0.00451055692798096
APOA2,Apolipoprotein A-II,Diet and food preferences,X20608.Liking for baked or steamed fish,33475,-0.0110382117457205,0.0375595437570128,-0.0846549175094656,0.0625784940180245,0.768851616618893
APOA2,Apolipoprotein A-II,Diet and food preferences,X20609.Liking for bananas,33475,-0.024005899100119,0.0382458138223588,-0.0989676941919423,0.0509558959917042,0.530232506879096
APOA2,Apolipoprotein A-II,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33475,-0.205214807654969,0.0373258039562971,-0.278373383409312,-0.132056231900627,3.94104601316302e-08
APOA2,Apolipoprotein A-II,Diet and food preferences,X20611.Liking for beef steak,33475,-0.146925461277279,0.0375687907937192,-0.220560291232969,-0.0732906313215894,9.26095261073183e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X20612.Liking for beetroot,33475,-0.0171633747711575,0.0375947275292528,-0.0908490407284929,0.0565222911861779,0.648014371448608
APOA2,Apolipoprotein A-II,Diet and food preferences,X20613.Liking for bell pepper,33475,-0.00758616017495499,0.0372382203577039,-0.0805730720760547,0.0654007517261447,0.838576838981476
APOA2,Apolipoprotein A-II,Diet and food preferences,X20614.Liking for bicycling,33475,0.116848242139216,0.036944127707726,0.0444377518320726,0.189258732446359,0.00156726467137505
APOA2,Apolipoprotein A-II,Diet and food preferences,X20615.Liking for biscuits,33475,-0.0703787700239025,0.0371411599370787,-0.143175443500577,0.00241790345277164,0.0581357001571815
APOA2,Apolipoprotein A-II,Diet and food preferences,X20616.Liking for bitter foods,33475,0.0828786937901896,0.0367048421503191,0.0109372031755641,0.154820184404815,0.023969432842161
APOA2,Apolipoprotein A-II,Diet and food preferences,X20617.Liking for bitter or ale,33475,0.0511573330363756,0.0375342675556986,-0.0224098313727936,0.124724497445545,0.172930190532448
APOA2,Apolipoprotein A-II,Diet and food preferences,X20618.Liking for black olives,33475,0.0995740372129804,0.0374408312984764,0.0261900078679668,0.172958066557994,0.00783856753978901
APOA2,Apolipoprotein A-II,Diet and food preferences,X20619.Liking for black pepper,33475,0.0889591838366672,0.0375763585023512,0.0153095211720589,0.162608846501275,0.0179320860809776
APOA2,Apolipoprotein A-II,Diet and food preferences,X20620.Liking for blue cheese,33475,0.108016624475553,0.0370175001394272,0.0354623242022753,0.18057092474883,0.00353114648045071
APOA2,Apolipoprotein A-II,Diet and food preferences,X20621.Liking for bolognese sauce,33475,-0.0837512492851098,0.0371737431457515,-0.156611785850783,-0.0108907127194368,0.024283641399807
APOA2,Apolipoprotein A-II,Diet and food preferences,X20622.Liking for broad beans,33475,0.0594404001339325,0.0372339552050629,-0.0135381520679908,0.132418952335856,0.110431726904646
APOA2,Apolipoprotein A-II,Diet and food preferences,X20623.Liking for broccoli,33475,0.0101810629398328,0.0383790767659193,-0.065041927521369,0.0854040534010345,0.790802243370415
APOA2,Apolipoprotein A-II,Diet and food preferences,X20624.Liking for brown rice,33475,0.00873716048134475,0.0371352626581669,-0.0640479543286624,0.0815222752913519,0.813996936445007
APOA2,Apolipoprotein A-II,Diet and food preferences,X20625.Liking for brussel sprouts,33475,0.0110903892145729,0.0374223574853026,-0.0622574314566202,0.0844382098857661,0.76696362978522
APOA2,Apolipoprotein A-II,Diet and food preferences,X20626.Liking for burgers (meat),33475,-0.153566059113796,0.0370843312808953,-0.226251348424351,-0.0808807698032415,3.4875939115563e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X20627.Liking for burn of spicy foods,33475,0.0548991858428746,0.0366411176954326,-0.0169174048401734,0.126715776525923,0.134089606269284
APOA2,Apolipoprotein A-II,Diet and food preferences,X20628.Liking for butter on bread,33475,0.0158392250697944,0.0376074793113519,-0.0578714343804554,0.0895498845200442,0.673638760596859
APOA2,Apolipoprotein A-II,Diet and food preferences,X20629.Liking for butternut squash,33475,0.0297489607693551,0.0371159881313879,-0.0429983759681652,0.102496297506875,0.422854331880654
APOA2,Apolipoprotein A-II,Diet and food preferences,X20630.Liking for cabbage,33475,0.0223069162003973,0.0374485946135775,-0.0510923292422146,0.0957061616430092,0.551411309743783
APOA2,Apolipoprotein A-II,Diet and food preferences,X20631.Liking for cake,33475,-0.0278050589566065,0.0371382807479721,-0.100596089222632,0.0449859713094188,0.454062410696845
APOA2,Apolipoprotein A-II,Diet and food preferences,X20632.Liking for cake icing,33475,-0.0249687552639567,0.0368739096330465,-0.0972416181447278,0.0473041076168145,0.498334193519367
APOA2,Apolipoprotein A-II,Diet and food preferences,X20633.Liking for capers,33475,0.0358765148066489,0.0368662528623266,-0.0363813408035112,0.108134370416809,0.330501631990909
APOA2,Apolipoprotein A-II,Diet and food preferences,X20634.Liking for cauliflower,33475,0.00840742628739759,0.0379471333986909,-0.0659689551740365,0.0827838077488317,0.824664017728652
APOA2,Apolipoprotein A-II,Diet and food preferences,X20635.Liking for cereal or granola bar,33475,-0.0416318030920756,0.0368711641048461,-0.113899284737574,0.0306356785534228,0.25887730706395
APOA2,Apolipoprotein A-II,Diet and food preferences,X20636.Liking for cheesecake,33475,-0.0459011940907586,0.0370371185275441,-0.118493946404745,0.0266915582232278,0.215253771030798
APOA2,Apolipoprotein A-II,Diet and food preferences,X20637.Liking for cherries,33475,0.0249863927735519,0.0387005361885664,-0.0508666581560383,0.100839443703142,0.51853165346013
APOA2,Apolipoprotein A-II,Diet and food preferences,X20638.Liking for chicken,33475,-0.178709108460859,0.0387695982647283,-0.254697521059726,-0.102720695861991,4.08813001896602e-06
APOA2,Apolipoprotein A-II,Diet and food preferences,X20639.Liking for chilli pepper,33475,0.0328789713979427,0.0369588945679133,-0.0395604619551674,0.105318404751053,0.373698060018154
APOA2,Apolipoprotein A-II,Diet and food preferences,X20640.Liking for chips or french fries,33475,0.012171057729432,0.0373476829820948,-0.0610304009154738,0.0853725163743377,0.744518300228868
APOA2,Apolipoprotein A-II,Diet and food preferences,X20641.Liking for cigarette smoking,33475,-0.0394302247025078,0.057975265822697,-0.153061745714994,0.0742012963099783,0.496443922842699
APOA2,Apolipoprotein A-II,Diet and food preferences,X20642.Liking for cod,33475,-0.0686814601288076,0.0378118863573927,-0.142792757389297,0.00542983713168207,0.0693403931722335
APOA2,Apolipoprotein A-II,Diet and food preferences,X20643.Liking for coffee with sugar,33475,-0.0772680530260759,0.0405748129517962,-0.156794686411596,0.00225858035944464,0.0568963597795539
APOA2,Apolipoprotein A-II,Diet and food preferences,X20644.Liking for coffee without sugar,33475,0.0377088288819882,0.0377734324851294,-0.0363270987888654,0.111744756552842,0.318164042656106
APOA2,Apolipoprotein A-II,Diet and food preferences,X20645.Liking for coriander,33475,0.00691862894428508,0.0371138714950901,-0.0658245591860915,0.0796618170746617,0.852122282412876
APOA2,Apolipoprotein A-II,Diet and food preferences,X20646.Liking for corn flakes,33475,-0.0696278248078615,0.0371151726891562,-0.142373563278608,0.00311791366288458,0.0606864643312823
APOA2,Apolipoprotein A-II,Diet and food preferences,X20647.Liking for cream,33475,-0.0797917413015101,0.0371068316178566,-0.152521131272509,-0.00706235133051109,0.0315544100072832
APOA2,Apolipoprotein A-II,Diet and food preferences,X20648.Liking for croissant,33475,0.0239433936948067,0.0370478660025206,-0.0486704236701337,0.0965572110597472,0.518111749612869
APOA2,Apolipoprotein A-II,Diet and food preferences,X20649.Liking for cucumber,33475,-0.0133559175894188,0.037426577094616,-0.0867120086948663,0.0600001735160286,0.721207069131205
APOA2,Apolipoprotein A-II,Diet and food preferences,X20650.Liking for curry,33475,0.0255720161951017,0.0376663860423836,-0.0482541004479702,0.0993981328381735,0.497212422019152
APOA2,Apolipoprotein A-II,Diet and food preferences,X20651.Liking for dairy products,33475,-0.0640487018084761,0.0377568048418398,-0.138052039298482,0.00995463568152986,0.089852288272593
APOA2,Apolipoprotein A-II,Diet and food preferences,X20652.Liking for dark chocolate,33475,0.00483846055631285,0.0371210099773822,-0.0679187189993562,0.0775956401119819,0.896297859621702
APOA2,Apolipoprotein A-II,Diet and food preferences,X20653.Liking for diet fizzy drinks,33475,-0.0441529911262802,0.0376452482039178,-0.117937677605959,0.0296316953533987,0.240876930252789
APOA2,Apolipoprotein A-II,Diet and food preferences,X20654.Liking for dried fruit,33475,-0.0676455247861228,0.037217008311105,-0.140590861075889,0.00529981150364299,0.0691568802569824
APOA2,Apolipoprotein A-II,Diet and food preferences,X20655.Liking for eggs,33475,-0.00955191947982635,0.0381511820033394,-0.0843282362063716,0.0652243972467189,0.802306418828217
APOA2,Apolipoprotein A-II,Diet and food preferences,X20656.Liking for exercising alone,33475,0.170899829345789,0.0368664851740436,0.0986415184046633,0.243158140286914,3.6052281783496e-06
APOA2,Apolipoprotein A-II,Diet and food preferences,X20657.Liking for exercising with others,33475,0.0391540741113382,0.0369174532455837,-0.0332041342500059,0.111512282472682,0.288905491095983
APOA2,Apolipoprotein A-II,Diet and food preferences,X20658.Liking for extra virgin olive oil,33475,0.0364770845812997,0.0378994298189547,-0.0378057978638514,0.110759967026451,0.335837522784601
APOA2,Apolipoprotein A-II,Diet and food preferences,X20659.Liking for fatty foods,33475,-0.013431733815305,0.0369372834342926,-0.0858288093465185,0.0589653417159086,0.716137684784732
APOA2,Apolipoprotein A-II,Diet and food preferences,X20660.Liking for fresh tomatoes,33475,-0.0131286517724764,0.0393906112913969,-0.0903342499036142,0.0640769463586615,0.738919692563222
APOA2,Apolipoprotein A-II,Diet and food preferences,X20661.Liking for fried chicken,33475,-0.19667835897749,0.0369506756386842,-0.269101683229311,-0.124255034725669,1.04528393757845e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X20662.Liking for fried or battered fish,33475,-0.0617482737368313,0.0372104347491638,-0.134680725845192,0.0111841783715297,0.0970609418050609
APOA2,Apolipoprotein A-II,Diet and food preferences,X20663.Liking for fruit,33475,-0.0662224886174123,0.0407828524124895,-0.146156879345892,0.013711902111067,0.10445501277906
APOA2,Apolipoprotein A-II,Diet and food preferences,X20664.Liking for garlic,33475,0.0381322924579915,0.0377847749586597,-0.0359258664609815,0.112190451376965,0.31290544596085
APOA2,Apolipoprotein A-II,Diet and food preferences,X20665.Liking for gherkins,33475,0.04819122463827,0.0368783907805732,-0.0240904212916535,0.120472870568193,0.191325344468283
APOA2,Apolipoprotein A-II,Diet and food preferences,X20666.Liking for globe artichoke,33475,0.10770784498364,0.0370812026432556,0.0350286878028588,0.180387002164421,0.00368504602756071
APOA2,Apolipoprotein A-II,Diet and food preferences,X20667.Liking for goat's cheese,33475,0.0419028754062199,0.0370522386424059,-0.0307195123328957,0.114525263145336,0.258119751203296
APOA2,Apolipoprotein A-II,Diet and food preferences,X20668.Liking for going to a cafe,33475,0.0217924479742842,0.0373440921924355,-0.0514019727228893,0.0949868686714577,0.559531349112319
APOA2,Apolipoprotein A-II,Diet and food preferences,X20669.Liking for going to the gym,33475,0.0522317846236211,0.0366054314512159,-0.019514861020762,0.123978430268004,0.153645203724027
APOA2,Apolipoprotein A-II,Diet and food preferences,X20670.Liking for going to the pub,33475,0.0572674214057228,0.0372458942494551,-0.0157345313232092,0.130269374134655,0.124191638643213
APOA2,Apolipoprotein A-II,Diet and food preferences,X20671.Liking for grapefruit,33475,0.0288983490048111,0.036786146167197,-0.0432024974828951,0.100999195492517,0.432134740342542
APOA2,Apolipoprotein A-II,Diet and food preferences,X20672.Liking for green olives,33475,0.0965630933932847,0.0376152088640998,0.0228372840196491,0.17028890276692,0.0102694470656426
APOA2,Apolipoprotein A-II,Diet and food preferences,X20673.Liking for haddock,33475,0.0307636816797524,0.0377243378765588,-0.043176020558303,0.104703383917808,0.414814207628078
APOA2,Apolipoprotein A-II,Diet and food preferences,X20674.Liking for ham,33475,-0.192055440228509,0.0373017800667078,-0.265166929159256,-0.118943951297762,2.67502278276361e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X20675.Liking for hard cheese,33475,0.00112919433360247,0.0381080506254276,-0.0735625848922356,0.0758209735594405,0.976361649961434
APOA2,Apolipoprotein A-II,Diet and food preferences,X20676.Liking for herring,33475,0.09099152075984,0.0371352387365531,0.0182064528361958,0.163776588683484,0.014292454747149
APOA2,Apolipoprotein A-II,Diet and food preferences,X20677.Liking for honey,33475,-0.018192250879967,0.037104665785493,-0.0909173958195332,0.0545328940595993,0.623936004899198
APOA2,Apolipoprotein A-II,Diet and food preferences,X20678.Liking for horseradish or wasabi,33475,-0.0163948658791844,0.0369246286896345,-0.0887671381108681,0.0559774063524993,0.657046109334937
APOA2,Apolipoprotein A-II,Diet and food preferences,X20679.Liking for ice cream,33475,-0.077447398063961,0.0372971816862867,-0.150549874169083,-0.00434492195883895,0.0378747499544523
APOA2,Apolipoprotein A-II,Diet and food preferences,X20680.Liking for jam,33475,-0.04114551183728,0.0369021321571706,-0.113473690865334,0.0311826671907744,0.264882560082455
APOA2,Apolipoprotein A-II,Diet and food preferences,X20681.Liking for kiwi fruit,33475,-0.065463866378606,0.0373372394365705,-0.138644855674284,0.00771712291707218,0.0795801925502109
APOA2,Apolipoprotein A-II,Diet and food preferences,X20682.Liking for lager,33475,-0.0460011876303882,0.0367879514224122,-0.118105572418316,0.0261031971575397,0.21116870688876
APOA2,Apolipoprotein A-II,Diet and food preferences,X20683.Liking for lamb,33475,-0.0881675099967881,0.0376594047918761,-0.161979943388865,-0.0143550766047109,0.0192431452657377
APOA2,Apolipoprotein A-II,Diet and food preferences,X20684.Liking for lemons,33475,0.0247270782141205,0.0369998386661517,-0.047792605571537,0.0972467619997779,0.503956686768753
APOA2,Apolipoprotein A-II,Diet and food preferences,X20685.Liking for lentils or beans,33475,0.0431635925850038,0.0374524523961416,-0.0302432141114336,0.116570399281441,0.249148283444965
APOA2,Apolipoprotein A-II,Diet and food preferences,X20686.Liking for liver,33475,-0.113955307346158,0.0374795283899755,-0.18741518299051,-0.0404954317018059,0.00236847100301929
APOA2,Apolipoprotein A-II,Diet and food preferences,X20687.Liking for mackerel,33475,0.112708782018999,0.0372145622739085,0.0397682399621385,0.18564932407586,0.00246325595762034
APOA2,Apolipoprotein A-II,Diet and food preferences,X20688.Liking for marzipan,33475,0.00839773705837877,0.0368143375410515,-0.0637583645220822,0.0805538386388397,0.819565190235856
APOA2,Apolipoprotein A-II,Diet and food preferences,X20689.Liking for mayonnaise,33475,0.0574407556654924,0.0370555507713354,-0.0151881238463249,0.13006963517731,0.121144330018398
APOA2,Apolipoprotein A-II,Diet and food preferences,X20690.Liking for melon,33475,-0.0758236695079498,0.0383270495996539,-0.150944686723271,-0.000702652292628184,0.047919668808323
APOA2,Apolipoprotein A-II,Diet and food preferences,X20691.Liking for milk chocolate,33475,-0.0343908020824334,0.0371638108050427,-0.107231871260317,0.0384502670954502,0.354789358294195
APOA2,Apolipoprotein A-II,Diet and food preferences,X20692.Liking for mushrooms,33475,-0.0126328961605888,0.0383835847871248,-0.0878647223433533,0.0625989300221757,0.742070376267058
APOA2,Apolipoprotein A-II,Diet and food preferences,X20694.Liking for orange juice,33475,-0.0774950443053007,0.0373164453369304,-0.150635277165684,-0.00435481144491702,0.0378558201769522
APOA2,Apolipoprotein A-II,Diet and food preferences,X20695.Liking for oranges,33475,-0.0820224982733929,0.0377151647122548,-0.155944221109412,-0.00810077543737339,0.0296703014021116
APOA2,Apolipoprotein A-II,Diet and food preferences,X20696.Liking for pasta,33475,-0.0449721467428027,0.0376679515669163,-0.118801331813959,0.0288570383283532,0.232542629521934
APOA2,Apolipoprotein A-II,Diet and food preferences,X20697.Liking for pears,33475,0.000431912508548993,0.0376558049523561,-0.073373465198069,0.074237290215167,0.990848693921983
APOA2,Apolipoprotein A-II,Diet and food preferences,X20698.Liking for pizza,33475,-0.0475534622028014,0.0370544320680038,-0.120180149056089,0.025073224650486,0.199403684768772
APOA2,Apolipoprotein A-II,Diet and food preferences,X20699.Liking for plain yogurt,33475,0.0189703510181028,0.0372308407689271,-0.0540020968889943,0.0919427989251999,0.610390208316128
APOA2,Apolipoprotein A-II,Diet and food preferences,X20700.Liking for plums,33475,-0.0102862236991032,0.0379011821548543,-0.0845725407226177,0.0640000933244113,0.786092422286494
APOA2,Apolipoprotein A-II,Diet and food preferences,X20701.Liking for pollock,33475,0.0106874559100666,0.0368946802263486,-0.0616261173335766,0.0830010291537097,0.7720713552202
APOA2,Apolipoprotein A-II,Diet and food preferences,X20702.Liking for pork chop,33475,-0.196749864747027,0.0371691441557033,-0.269601387292205,-0.123898342201849,1.22735768907125e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X20703.Liking for porridge,33475,0.011793676735344,0.0375471455166992,-0.0617987284773865,0.0853860819480746,0.753449516983567
APOA2,Apolipoprotein A-II,Diet and food preferences,X20704.Liking for potato crisps,33475,0.0347967790583628,0.037257712111411,-0.0382283366800028,0.107821894796728,0.350354007304634
APOA2,Apolipoprotein A-II,Diet and food preferences,X20705.Liking for potatoes,33475,0.0754048980583303,0.0376685731384312,0.00157449470700528,0.149235301409655,0.0453344592746411
APOA2,Apolipoprotein A-II,Diet and food preferences,X20706.Liking for prawns,33475,0.00373629890623401,0.0376549526606953,-0.0700674083087287,0.0775400061211967,0.920961986519418
APOA2,Apolipoprotein A-II,Diet and food preferences,X20707.Liking for raw carrots,33475,0.0927372654444752,0.0375180337071774,0.0192019193784074,0.166272611510543,0.0134604822445949
APOA2,Apolipoprotein A-II,Diet and food preferences,X20708.Liking for red meat,33475,-0.191434360736139,0.0375903359640684,-0.265111419225713,-0.117757302246565,3.59798136293092e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X20709.Liking for red wine,33475,0.044673350181876,0.0372509905750409,-0.0283385913452042,0.117685291708956,0.230459290253673
APOA2,Apolipoprotein A-II,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33475,-0.101574350552224,0.0381094950104714,-0.176268960772748,-0.0268797403316998,0.0077041614453698
APOA2,Apolipoprotein A-II,Diet and food preferences,X20711.Liking for roast chicken,33475,-0.183618791358942,0.0390448708579604,-0.260146738240544,-0.10709084447734,2.60240851710334e-06
APOA2,Apolipoprotein A-II,Diet and food preferences,X20712.Liking for salad dressing,33475,0.0336377265538389,0.0370793376710346,-0.0390377752813889,0.106313228389067,0.364333048014833
APOA2,Apolipoprotein A-II,Diet and food preferences,X20713.Liking for salad leaves,33475,0.00114908876684568,0.0382014006650254,-0.0737256565366042,0.0760238340702956,0.976004071603965
APOA2,Apolipoprotein A-II,Diet and food preferences,X20714.Liking for salami,33475,-0.0297489882922324,0.0368632268192401,-0.102000912857943,0.0425029362734781,0.419680770695157
APOA2,Apolipoprotein A-II,Diet and food preferences,X20715.Liking for salmon,33475,0.0318451092882826,0.0387646831136289,-0.0441336696144301,0.107823888190995,0.411383055851577
APOA2,Apolipoprotein A-II,Diet and food preferences,X20716.Liking for salty foods,33475,0.0803824123866733,0.0370961751500688,0.00767390909253846,0.153090915680808,0.0302696307366339
APOA2,Apolipoprotein A-II,Diet and food preferences,X20717.Liking for salty pretzels,33475,-0.019869606286678,0.0368996252009413,-0.092192871680523,0.052453659107167,0.590260129326086
APOA2,Apolipoprotein A-II,Diet and food preferences,X20718.Liking for sardines,33475,0.0841724186488462,0.0371512496669998,0.0113559693015266,0.156988867996166,0.023493845537769
APOA2,Apolipoprotein A-II,Diet and food preferences,X20719.Liking for sausages (meat),33475,-0.129592396323726,0.0372608532292438,-0.202623668653044,-0.0565611239944078,0.000507450346122991
APOA2,Apolipoprotein A-II,Diet and food preferences,X20720.Liking for savoury biscuits,33475,0.0347623718544889,0.0372358082660148,-0.0382198123469001,0.107744556055878,0.35054729435074
APOA2,Apolipoprotein A-II,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33475,0.0748476624550447,0.037199534748944,0.00193657434711442,0.147758750562975,0.0442415722288489
APOA2,Apolipoprotein A-II,Diet and food preferences,X20722.Liking for skimmed milk,33475,-0.019268037278561,0.0370353245188117,-0.0918572733354319,0.05332119877831,0.602893620628943
APOA2,Apolipoprotein A-II,Diet and food preferences,X20723.Liking for smoked fish,33475,0.0938571226359082,0.0374070786305477,0.0205392485200348,0.167174996751782,0.0121211472067005
APOA2,Apolipoprotein A-II,Diet and food preferences,X20724.Liking for soft cheese,33475,-0.0244279360537841,0.0368790121943888,-0.0967107999547861,0.0478549278472179,0.507743331681671
APOA2,Apolipoprotein A-II,Diet and food preferences,X20725.Liking for soy sauce,33475,-0.0174227927502808,0.0373210826850387,-0.0905721148129567,0.055726529312395,0.64062842223889
APOA2,Apolipoprotein A-II,Diet and food preferences,X20726.Liking for soya milk,33475,0.047196850926942,0.0372277517848953,-0.0257695425714528,0.120163244425337,0.204904839158268
APOA2,Apolipoprotein A-II,Diet and food preferences,X20727.Liking for spicy foods,33475,0.0373082921769448,0.0371099995676367,-0.0354273069756231,0.110043891329513,0.314756859417925
APOA2,Apolipoprotein A-II,Diet and food preferences,X20728.Liking for spinach,33475,0.0650338797884547,0.0376237648765667,-0.00870869936961602,0.138776458946526,0.0839250305653263
APOA2,Apolipoprotein A-II,Diet and food preferences,X20729.Liking for spirits,33475,0.0747581419067527,0.0369588636503012,0.00231876915216229,0.147197514661343,0.0431276940105583
APOA2,Apolipoprotein A-II,Diet and food preferences,X20730.Liking for strawberries,33475,-0.127895553743664,0.0403600680588075,-0.207001287138926,-0.0487898203484008,0.0015351604188142
APOA2,Apolipoprotein A-II,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33475,-0.106503488344522,0.038126407261752,-0.181231246577556,-0.0317757301114886,0.00522553969148596
APOA2,Apolipoprotein A-II,Diet and food preferences,X20732.Liking for sweet foods,33475,-0.0404114024507222,0.0369024816554684,-0.11274026649544,0.0319174615939959,0.273506281761399
APOA2,Apolipoprotein A-II,Diet and food preferences,X20733.Liking for taking the stairs,33475,0.0636231091992213,0.0381029736481507,-0.011058719151154,0.138304937549597,0.0949979439770755
APOA2,Apolipoprotein A-II,Diet and food preferences,X20734.Liking for tea with sugar,33475,-0.0782758606368104,0.0446116499572059,-0.165714694552934,0.00916297327931312,0.079358635121859
APOA2,Apolipoprotein A-II,Diet and food preferences,X20735.Liking for tea without sugar,33475,-0.0142523889621652,0.03865754897828,-0.090021184959594,0.0615164070352635,0.712371995395614
APOA2,Apolipoprotein A-II,Diet and food preferences,X20736.Liking for tomato ketchup,33475,-0.0778850599426981,0.0369783219627815,-0.15036257098975,-0.0054075488956464,0.03520976188805
APOA2,Apolipoprotein A-II,Diet and food preferences,X20737.Liking for tinned tuna,33475,-0.0144401352414286,0.0374038525896013,-0.0877516863170472,0.05887141583419,0.699460705494547
APOA2,Apolipoprotein A-II,Diet and food preferences,X20738.Liking for turnip (white),33475,0.0536882216301788,0.0369543645677592,-0.0187423329226292,0.126118776182987,0.146305035694992
APOA2,Apolipoprotein A-II,Diet and food preferences,X20739.Liking for vegetables,33475,0.0499825574193121,0.0409640572239079,-0.0303069947395475,0.130272109578172,0.222435536966061
APOA2,Apolipoprotein A-II,Diet and food preferences,X20740.Liking for vinegar,33475,-0.0838092282092451,0.0368884652541546,-0.156110620107388,-0.011507836311102,0.023110755836171
APOA2,Apolipoprotein A-II,Diet and food preferences,X20741.Liking for watching television,33475,-0.0381011983387192,0.0377291216694205,-0.112050276810783,0.0358478801333451,0.31258694749534
APOA2,Apolipoprotein A-II,Diet and food preferences,X20742.Liking for whisky,33475,0.0700465477611034,0.0382737453455608,-0.00496999311619573,0.145063088638403,0.06725905734866
APOA2,Apolipoprotein A-II,Diet and food preferences,X20743.Liking for white bread,33475,0.00425114427495262,0.0369979770755807,-0.0682648907931855,0.0767671793430908,0.908525143238129
APOA2,Apolipoprotein A-II,Diet and food preferences,X20744.Liking for white rice,33475,-0.0461111367738017,0.0371994610606692,-0.119022080452713,0.0267998069051099,0.215166745861488
APOA2,Apolipoprotein A-II,Diet and food preferences,X20745.Liking for white wine,33475,0.0779435314834434,0.0368643213298643,0.00568946167690933,0.150197601289978,0.0345123434723646
APOA2,Apolipoprotein A-II,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33475,-0.110422515540368,0.0374560158859446,-0.18383630667682,-0.037008724403917,0.00320546457577442
APOA2,Apolipoprotein A-II,Diet and food preferences,X20747.Liking for whole milk,33475,-0.0595773292945962,0.0371329052760527,-0.13235782363566,0.0132031650464671,0.108651096461568
APOA2,Apolipoprotein A-II,Diet and food preferences,X20748.Liking for wholemeal bread,33475,0.00217004813709852,0.038808766815801,-0.0738951348218714,0.0782352310960684,0.955409535860444
APOA2,Apolipoprotein A-II,Diet and food preferences,X20749.Liking for working up a sweat,33475,0.124691043796572,0.0369997781479123,0.052171478626664,0.19721060896648,0.000754509332532542
APOA2,Apolipoprotein A-II,Physical measures,X21001.Body mass index (BMI),48365,-0.19117106085025,0.0131733802197868,-0.216990886081032,-0.165351235619468,1.60362730786556e-47
APOA2,Apolipoprotein A-II,Physical measures,X21002.Weight,48384,-0.0340956461877248,0.00775162907769927,-0.0492888391800153,-0.0189024531954342,1.09453610356543e-05
APOA2,Apolipoprotein A-II,Physical measures,X21021.Pulse wave Arterial Stiffness index,31939,-0.0144724534348816,0.00610169094223238,-0.0264317676816571,-0.00251313918810615,0.0177213341418658
APOA2,Apolipoprotein A-II,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,33007,-0.00444150068161506,0.0393556847011368,-0.0815786426958433,0.0726956413326132,0.910147691186909
APOA2,Apolipoprotein A-II,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,33007,-0.000729737597164686,0.0415049351199973,-0.0820794104323593,0.08061993523803,0.985972741721798
APOA2,Apolipoprotein A-II,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,33008,-0.0303573071024202,0.0406477987475535,-0.110026992647625,0.0493123784427845,0.455180756737683
APOA2,Apolipoprotein A-II,Health and medical history,X21040.Satisfaction with bowel habits,32980,-0.0504232453130863,0.0378259645243444,-0.124562135780801,0.0237156451546288,0.182554424089028
APOA2,Apolipoprotein A-II,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32982,-0.056631248049894,0.0400096349115963,-0.135050132476623,0.0217876363768347,0.15697362470612
APOA2,Apolipoprotein A-II,Health and medical history,X21042.Greatest number of times bowels opened per day,32972,-0.0129304699411941,0.0412339263046271,-0.0937489654982632,0.0678880256158751,0.753841052941774
APOA2,Apolipoprotein A-II,Health and medical history,X21043.Least number of times bowels opened per week,32917,-0.0357905466836146,0.0408499076859976,-0.11585636574817,0.0442752723809408,0.380973062587827
APOA2,Apolipoprotein A-II,Health and medical history,X21044.Average number of times bowels opened per day,32953,-0.0429105719830644,0.0453183150059765,-0.131734469394778,0.0459133254286495,0.343729995783351
APOA2,Apolipoprotein A-II,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,33012,0.0129614577201651,0.0411543589861967,-0.0677010858927803,0.0936240013331106,0.752808784262615
APOA2,Apolipoprotein A-II,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,33006,-0.00553744529792346,0.0413252970506664,-0.0865350275172295,0.0754601369213826,0.893408288136593
APOA2,Apolipoprotein A-II,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,29217,0.0312741305775405,0.0611345565850826,-0.0885496003292214,0.151097861484302,0.608978508536312
APOA2,Apolipoprotein A-II,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,33009,0.0473628612171222,0.0435616270446325,-0.0380179277903576,0.132743650224602,0.276950094029486
APOA2,Apolipoprotein A-II,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,33007,0.11773472116547,0.0610180195159454,-0.00186059708578258,0.237330039416723,0.0536987954032926
APOA2,Apolipoprotein A-II,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,33010,0.031739121011802,0.0488484648748483,-0.0640038701429007,0.127482112166505,0.515872269070935
APOA2,Apolipoprotein A-II,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,33008,-0.209158378784023,0.119023349021613,-0.442444142866386,0.024127385298339,0.0789020738457406
APOA2,Apolipoprotein A-II,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,33010,0.0358573919030757,0.0462442396248974,-0.0547813177617232,0.126496101567875,0.438128377008721
APOA2,Apolipoprotein A-II,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,33010,0.0575100784918936,0.0481171947567527,-0.0367996232313416,0.151819780215129,0.232036571880162
APOA2,Apolipoprotein A-II,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32787,0.0173432660585381,0.043298631944988,-0.0675220525536385,0.102208584670715,0.688761068146284
APOA2,Apolipoprotein A-II,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,33010,0.00636974075334641,0.0426257610953813,-0.077176750993601,0.0899162325002938,0.881214427287028
APOA2,Apolipoprotein A-II,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,33011,0.0446666831042864,0.058494411249366,-0.0699823629444709,0.159315729153044,0.445121763918789
APOA2,Apolipoprotein A-II,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,33010,0.0366152205848615,0.0409542976695186,-0.0436552028473949,0.116885644017118,0.371318255650672
APOA2,Apolipoprotein A-II,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,33009,0.0068451845096844,0.0411375548768183,-0.0737844230488796,0.0874747920682484,0.867847852672279
APOA2,Apolipoprotein A-II,Working and living environment,X21100.Water hardness (USGS classification),48163,0.0090975390439054,0.0246261360286601,-0.0391696875722685,0.0573647656600793,0.711813315610751
APOA2,Apolipoprotein A-II,Lifestyle factors,X2139.Age first had sexual intercourse,45753,-0.000793157780925799,0.00356964463034558,-0.00778966125640313,0.00620334569455153,0.824164029701128
APOA2,Apolipoprotein A-II,Health and medical history,X2149.Lifetime number of sexual partners,43984,-0.00505880532565219,0.0278337646236281,-0.0596129839879633,0.0494953733366589,0.855780231099532
APOA2,Apolipoprotein A-II,Physical activities,X22032.IPAQ activity group,43990,0.108476857855653,0.0268932150456881,0.055766156366104,0.161187559345201,5.51280275794629e-05
APOA2,Apolipoprotein A-II,Physical activities,X22033.Summed days activity,44502,0.0172508529964932,0.00343643267134427,0.0105154449606584,0.023986261032328,5.21044833467384e-07
APOA2,Apolipoprotein A-II,Physical activities,X22034.Summed minutes activity,43990,0.0102296925139621,0.00350034245696977,0.00336902129830137,0.0170903637296229,0.0034763844676732
APOA2,Apolipoprotein A-II,Physical activities,X22037.MET minutes per week for walking,43307,0.00634290320428034,0.00345038049110585,-0.000419842558287135,0.0131056489668478,0.0660305186241833
APOA2,Apolipoprotein A-II,Physical activities,X22038.MET minutes per week for moderate activity,43990,0.0143138926571212,0.00358970792893591,0.0072780651164068,0.0213497201978356,6.70142999692531e-05
APOA2,Apolipoprotein A-II,Physical activities,X22039.MET minutes per week for vigorous activity,43990,0.0977666213756624,0.0269472351051432,0.0449500405695816,0.150583202181743,0.000286247261482332
APOA2,Apolipoprotein A-II,Physical activities,X22040.Summed MET minutes per week for all activity,43307,0.0145369129722105,0.00354856049314955,0.00758173440563735,0.0214920915387836,4.21021567228802e-05
APOA2,Apolipoprotein A-II,Eye measures,X2217.Age started wearing glasses or contact lenses,43475,-0.00341886011493336,0.0041128511319797,-0.0114800483336136,0.00464232810374685,0.405835307823459
APOA2,Apolipoprotein A-II,Working and living environment,X22501.Year ended full time education,30132,0.010947283069771,0.0177334432149125,-0.0238102656314576,0.0457048317709996,0.537043339382391
APOA2,Apolipoprotein A-II,Lifestyle factors,X22506.Tobacco smoking,30091,0.10893435074962,0.0967308826402641,-0.0806581792252977,0.298526880724537,0.260141623626269
APOA2,Apolipoprotein A-II,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46703,0.120441540042684,0.0538375706062632,0.0149199016544086,0.22596317843096,0.0252875783103398
APOA2,Apolipoprotein A-II,Physical measures,X23098.Weight,48057,-0.0331552808777676,0.00780730601386701,-0.0484576006649469,-0.0178529610905883,2.17752244281876e-05
APOA2,Apolipoprotein A-II,Physical measures,X23099.Body fat percentage,48035,-0.036070883506678,0.00755364987939774,-0.0508760372702976,-0.0212657297430585,1.80497364225979e-06
APOA2,Apolipoprotein A-II,Physical measures,X23100.Whole body fat mass,48004,-0.0533118140775611,0.00717436231743448,-0.0673735642197326,-0.0392500639353895,1.11459923484325e-13
APOA2,Apolipoprotein A-II,Physical measures,X23101.Whole body fat-free mass,48053,-0.0214588625497452,0.00667233906048585,-0.0345366471082974,-0.0083810779911929,0.00130119510678117
APOA2,Apolipoprotein A-II,Physical measures,X23102.Whole body water mass,48057,-0.0213213972240797,0.00667247911405416,-0.0343994562876258,-0.00824333816053355,0.00139804891820881
APOA2,Apolipoprotein A-II,Physical measures,X23104.Body mass index (BMI),48057,-0.188413535315686,0.0132850221362455,-0.214452178702727,-0.162374891928645,1.79172398401957e-45
APOA2,Apolipoprotein A-II,Physical measures,X23105.Basal metabolic rate,48055,-0.022806820969075,0.00714872672908479,-0.0368183253580812,-0.00879531658006882,0.00142290075439741
APOA2,Apolipoprotein A-II,Physical measures,X23106.Impedance of whole body,48054,0.0178880519914234,0.00547792729081671,0.00715131450142263,0.0286247894814241,0.00109431344270756
APOA2,Apolipoprotein A-II,Physical measures,X23107.Impedance of leg (right),48054,-0.0112604114576806,0.0045234883815606,-0.0201264486855393,-0.0023943742298218,0.0128054256163866
APOA2,Apolipoprotein A-II,Physical measures,X23108.Impedance of leg (left),48053,-0.0112281081956602,0.00448169593550644,-0.0200122322292528,-0.00244398416206754,0.0122403838867085
APOA2,Apolipoprotein A-II,Physical measures,X23109.Impedance of arm (right),48048,0.0426017567810231,0.00549284726960794,0.0318357761325916,0.0533677374294547,9.11969756358636e-15
APOA2,Apolipoprotein A-II,Physical measures,X23110.Impedance of arm (left),48052,0.0446946149086958,0.00548679072649807,0.0339405050847596,0.0554487247326321,3.94638905257509e-16
APOA2,Apolipoprotein A-II,Physical measures,X23111.Leg fat percentage (right),48053,-0.0702184881599837,0.00932921093381953,-0.08850374159027,-0.0519332347296975,5.3839238220193e-14
APOA2,Apolipoprotein A-II,Physical measures,X23112.Leg fat mass (right),48052,-0.0956483314586543,0.00963118410704028,-0.114525452308453,-0.0767712106088553,3.37676562913805e-23
APOA2,Apolipoprotein A-II,Physical measures,X23113.Leg fat-free mass (right),48052,-0.000227711913302739,0.00717870867217491,-0.0142979809107656,0.0138425570841601,0.974695243160063
APOA2,Apolipoprotein A-II,Physical measures,X23114.Leg predicted mass (right),48051,0.000231312199035998,0.00721086061068041,-0.0139019745978976,0.0143645989959696,0.974409867805353
APOA2,Apolipoprotein A-II,Physical measures,X23115.Leg fat percentage (left),48050,-0.0730704479589821,0.00963860447204473,-0.0919621127241898,-0.0541787831937745,3.55154616089983e-14
APOA2,Apolipoprotein A-II,Physical measures,X23116.Leg fat mass (left),48050,-0.0964028737466964,0.0100100690897273,-0.116022609162562,-0.0767831383308309,6.50178317729564e-22
APOA2,Apolipoprotein A-II,Physical measures,X23117.Leg fat-free mass (left),48048,-0.00414720912932596,0.00744680870778197,-0.0187429541965786,0.0104485359379267,0.57759344227318
APOA2,Apolipoprotein A-II,Physical measures,X23118.Leg predicted mass (left),48047,-0.00463023553180961,0.00747643640589978,-0.0192840508873732,0.010023579823754,0.535717665136201
APOA2,Apolipoprotein A-II,Physical measures,X23119.Arm fat percentage (right),48047,-0.0196454706707174,0.00836579117867399,-0.0360424213809184,-0.00324851996051633,0.0188668280915009
APOA2,Apolipoprotein A-II,Physical measures,X23120.Arm fat mass (right),48047,-0.050912132867999,0.00814667184786328,-0.066879609689811,-0.034944656046187,4.18801230852634e-10
APOA2,Apolipoprotein A-II,Physical measures,X23121.Arm fat-free mass (right),48046,-0.0368604529771898,0.00668312185708532,-0.0499593718170771,-0.0237615341373026,3.51438884643824e-08
APOA2,Apolipoprotein A-II,Physical measures,X23122.Arm predicted mass (right),48045,-0.0388402834373214,0.00668577052259685,-0.0519443936616112,-0.0257361732130316,6.34845071003807e-09
APOA2,Apolipoprotein A-II,Physical measures,X23123.Arm fat percentage (left),48041,-0.0182131720135312,0.00855585264540725,-0.0349826431985294,-0.00144370082853297,0.0332859885941879
APOA2,Apolipoprotein A-II,Physical measures,X23124.Arm fat mass (left),48041,-0.0490401283563008,0.00811496672223822,-0.0649454631318877,-0.0331347935807139,1.53325058550794e-09
APOA2,Apolipoprotein A-II,Physical measures,X23125.Arm fat-free mass (left),48037,-0.0369040808956105,0.00678354741626263,-0.0501998338314853,-0.0236083279597358,5.37269950938339e-08
APOA2,Apolipoprotein A-II,Physical measures,X23126.Arm predicted mass (left),48036,-0.0351315633806529,0.00682235796576643,-0.0485033849935551,-0.0217597417677507,2.63263323927224e-07
APOA2,Apolipoprotein A-II,Physical measures,X23127.Trunk fat percentage,48034,-0.0183886107430678,0.00541863465999088,-0.0290091346766499,-0.00776808680948569,0.00069094215445132
APOA2,Apolipoprotein A-II,Physical measures,X23128.Trunk fat mass,48030,-0.032624359195167,0.00590424031109762,-0.0441966702049183,-0.0210520481854157,3.31782402097319e-08
APOA2,Apolipoprotein A-II,Physical measures,X23129.Trunk fat-free mass,48025,-0.0238851132342891,0.00607343517425159,-0.0357890461758223,-0.011981180292756,8.42248333020772e-05
APOA2,Apolipoprotein A-II,Physical measures,X23130.Trunk predicted mass,48023,-0.0226658011390926,0.0060648825112907,-0.0345529708612223,-0.0107786314169628,0.00018649443849902
APOA2,Apolipoprotein A-II,NMR metabolomics,X23400.Total Cholesterol,37445,0.0444938361699322,0.00464034466596831,0.0353987606246343,0.0535889117152301,1.0471860235224e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37445,0.00565416360356857,0.00451205219779476,-0.00318945870410916,0.0144977859112463,0.210181932452734
APOA2,Apolipoprotein A-II,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37445,-0.0168774827239929,0.00452936782670313,-0.025755043664331,-0.00799992178365477,0.000195149989756571
APOA2,Apolipoprotein A-II,NMR metabolomics,X23403.VLDL Cholesterol,37445,-0.044217643352378,0.00444132867102474,-0.0529226475475865,-0.0355126391571695,2.85403576077797e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23404.Clinical LDL Cholesterol,37445,0.0223111685375181,0.00450348215167834,0.0134843435202286,0.0311379935548077,7.35009814012502e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23405.LDL Cholesterol,37445,0.0258855816249332,0.00446570797485499,0.0171327939942174,0.034638369255649,6.92069903076827e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23406.HDL Cholesterol,37445,0.13671359609619,0.00497130633079888,0.126969835687824,0.146457356504556,4.55075107385755e-162
APOA2,Apolipoprotein A-II,NMR metabolomics,X23407.Total Triglycerides,37445,-0.0628635738398492,0.00454497440353581,-0.0717717236707794,-0.0539554240089191,3.23178064502148e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23408.Triglycerides in VLDL,37445,-0.0708871167076338,0.00460984235291262,-0.0799224077193426,-0.0618518256959251,6.47943872285814e-53
APOA2,Apolipoprotein A-II,NMR metabolomics,X23409.Triglycerides in LDL,37445,-0.0284890088279744,0.0043687166965328,-0.0370516935531787,-0.0199263241027701,7.22433275853422e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23410.Triglycerides in HDL,37445,-0.0280676263821942,0.00431274777711827,-0.036520612025346,-0.0196146407390424,7.87979973431981e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37445,0.0383539605929731,0.00459748714419939,0.0293428857903423,0.0473650353956039,7.97795099981092e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23412.Phospholipids in VLDL,37445,-0.059978214599827,0.00447586737034283,-0.068750914645699,-0.0512055145539551,1.09072192172179e-40
APOA2,Apolipoprotein A-II,NMR metabolomics,X23413.Phospholipids in LDL,37445,0.0161668319445339,0.0044716829528044,0.0074023333570373,0.0249313305320306,0.000300992821957631
APOA2,Apolipoprotein A-II,NMR metabolomics,X23414.Phospholipids in HDL,37445,0.0884641996827848,0.00472673526259872,0.0791997985680913,0.0977286007974783,3.43744007677854e-77
APOA2,Apolipoprotein A-II,NMR metabolomics,X23415.Total Esterified Cholesterol,37445,0.0529226318569056,0.00465212687690324,0.0438044631781752,0.0620408005356359,7.51483622117573e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37445,-0.0370892287842744,0.00444727916884536,-0.0458058959552113,-0.0283725616133375,8.15561443447836e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37445,0.0205899777557443,0.00445059150613087,0.0118668184037278,0.0293131371077608,3.75610675880645e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37445,0.143920965430233,0.00494630446339189,0.134226208681985,0.153615722178481,1.29254574060443e-180
APOA2,Apolipoprotein A-II,NMR metabolomics,X23419.Total Free Cholesterol,37445,0.0227932246483221,0.00460202053548224,0.0137732643987769,0.0318131848978673,7.40046117731908e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23420.Free Cholesterol in VLDL,37445,-0.0524780963548926,0.00445844591400121,-0.0612166503463349,-0.0437395423634502,7.90836642171404e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23421.Free Cholesterol in LDL,37445,0.039661957581587,0.00451297017939298,0.0308165360299768,0.0485073791331973,1.69658273670211e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23422.Free Cholesterol in HDL,37445,0.103040130495698,0.00498408051912524,0.0932713326782127,0.112808928313184,1.62862359276312e-93
APOA2,Apolipoprotein A-II,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37445,0.0118746959487645,0.00448788066781272,0.00307844983985155,0.0206709420576774,0.00815563376883442
APOA2,Apolipoprotein A-II,NMR metabolomics,X23424.Total Lipids in VLDL,37445,-0.0645603348493005,0.00451397709787543,-0.0734077299611364,-0.0557129397374647,4.57022689355418e-46
APOA2,Apolipoprotein A-II,NMR metabolomics,X23425.Total Lipids in LDL,37445,0.0201638717850718,0.00446270189879009,0.0114169760634432,0.0289107675067003,6.28609062595627e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23426.Total Lipids in HDL,37445,0.106191366081896,0.00481045439660682,0.0967628754645464,0.115619856699245,3.98357814601311e-106
APOA2,Apolipoprotein A-II,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37445,0.110632741545557,0.00452749611718814,0.101758849155868,0.119506633935246,4.27889633020074e-129
APOA2,Apolipoprotein A-II,NMR metabolomics,X23428.Concentration of VLDL Particles,37445,-0.0437976566884907,0.00443309316839506,-0.052486519298545,-0.0351087940784364,6.09184649652256e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23429.Concentration of LDL Particles,37445,-0.00872163943957457,0.00447036403409931,-0.0174835529464092,4.02740672600793e-05,0.0510786599913203
APOA2,Apolipoprotein A-II,NMR metabolomics,X23430.Concentration of HDL Particles,37445,0.117826336678494,0.00451118963985257,0.108984404984383,0.126668268372605,9.11215159291787e-147
APOA2,Apolipoprotein A-II,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37445,-0.0734917826258433,0.00483644162226923,-0.082971208205491,-0.0640123570461956,1.00892172300589e-51
APOA2,Apolipoprotein A-II,NMR metabolomics,X23432.Average Diameter for LDL Particles,37445,0.0130705401511015,0.00446430121940464,0.0043205097610684,0.0218205705411346,0.00341946087548144
APOA2,Apolipoprotein A-II,NMR metabolomics,X23433.Average Diameter for HDL Particles,37445,0.0676369173126526,0.00514290180564082,0.0575568297735966,0.0777170048517086,2.89768704800497e-39
APOA2,Apolipoprotein A-II,NMR metabolomics,X23434.Phosphoglycerides,37433,0.0463168687348387,0.00453472999367388,0.0374287979472379,0.0552049395224395,2.10735778444129e-24
APOA2,Apolipoprotein A-II,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37433,-0.104269633846348,0.00481781068766222,-0.113712542794165,-0.0948267248985296,3.77667519462124e-102
APOA2,Apolipoprotein A-II,NMR metabolomics,X23436.Total Cholines,37433,0.0568832122913722,0.00460549071835005,0.0478564504834061,0.0659099740993383,7.38741974374027e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23437.Phosphatidylcholines,37433,0.0563922926870669,0.00459156185810096,0.047392831445189,0.0653917539289448,1.73085457905398e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23438.Sphingomyelins,37432,0.0718924732140696,0.004739629832319,0.0626027987427244,0.0811821476854149,1.51494324729901e-51
APOA2,Apolipoprotein A-II,NMR metabolomics,X23439.Apolipoprotein B,37445,-0.0147457725602365,0.0044852176464058,-0.0235367991471919,-0.00595474597328116,0.00101288166909895
APOA2,Apolipoprotein A-II,NMR metabolomics,X23440.Apolipoprotein A1,37445,0.111936113264689,0.00466169870859488,0.102799183795843,0.121073042733535,8.18836729101501e-125
APOA2,Apolipoprotein A-II,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37445,-0.0706717681286067,0.00443546152897482,-0.0793652727253974,-0.0619782635318161,1.21111932972139e-56
APOA2,Apolipoprotein A-II,NMR metabolomics,X23442.Total Fatty Acids,37433,-0.0123691872495326,0.00436796316111018,-0.0209303950453085,-0.00380797945375664,0.00463552675279499
APOA2,Apolipoprotein A-II,NMR metabolomics,X23443.Degree of Unsaturation,37433,0.0549118045055871,0.00480497861939793,0.0454940464115672,0.064329562599607,4.15496997394379e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23444.Omega-3 Fatty Acids,37433,-0.00472475383277191,0.00443889993599519,-0.0134249977073225,0.00397549004177865,0.287167617271658
APOA2,Apolipoprotein A-II,NMR metabolomics,X23445.Omega-6 Fatty Acids,37433,0.023874278106124,0.00443459378052652,0.015182474296292,0.032566081915956,7.42070327169103e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37433,0.0197953388727711,0.00444042376844231,0.0110921082866242,0.028498569458918,8.33973843437426e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37433,-0.0291637697082546,0.00443386038674751,-0.0378541360662798,-0.0204734033502295,4.95910163715511e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23448.Saturated Fatty Acids,37433,-0.0218005076347025,0.00438343924841371,-0.0303920485615934,-0.0132089667078116,6.66000086725469e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23449.Linoleic Acid,37433,0.0234408339483746,0.00446669739888554,0.0146861070465589,0.0321955608501902,1.56150129646746e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23450.Docosahexaenoic Acid,37433,0.0489845915349287,0.00462064863137366,0.0399281202174363,0.058041062852421,3.72140508531286e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37433,0.00193575454780169,0.00448559848951293,-0.00685601849164365,0.010727527587247,0.666076247538759
APOA2,Apolipoprotein A-II,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37433,0.0619524356069604,0.00453582234376172,0.0530622238131875,0.0708426474007334,3.41480406264896e-42
APOA2,Apolipoprotein A-II,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37433,0.0674014893546745,0.0047096732049293,0.058170529873013,0.0766324488363359,4.02770637876289e-46
APOA2,Apolipoprotein A-II,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37433,-0.0607408921357287,0.00483107009731989,-0.0702097895264757,-0.0512719947449817,4.72197829601503e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37433,-0.0441277234430778,0.00435054942016023,-0.0526548003065919,-0.0356006465795638,4.33726900341686e-24
APOA2,Apolipoprotein A-II,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37433,0.0657288389476156,0.00464233977886298,0.0566298529810442,0.0748278249141871,3.4666628840453e-45
APOA2,Apolipoprotein A-II,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37433,0.0561085230809106,0.00466296657798764,0.0469691085880549,0.0652479375737664,3.52435401698531e-33
APOA2,Apolipoprotein A-II,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37433,0.0670070789070697,0.00481752885316879,0.0575647223548589,0.0764494354592805,1.11329798714481e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37431,0.0152620960124276,0.00444804464823478,0.00654392850188739,0.0239802635229677,0.000602724986247701
APOA2,Apolipoprotein A-II,NMR metabolomics,X23460.Alanine,37441,0.00471217984144396,0.00435191195326885,-0.00381756758696299,0.0132419272698509,0.278923613419608
APOA2,Apolipoprotein A-II,NMR metabolomics,X23461.Glutamine,37400,0.0236899174759274,0.0042862761599404,0.0152888162024443,0.0320910187494106,3.31920072326107e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23462.Glycine,37431,0.0604381307753613,0.0044614432614987,0.0516937019828239,0.0691825595678988,1.54155164640297e-41
APOA2,Apolipoprotein A-II,NMR metabolomics,X23463.Histidine,37430,-0.0148139042995758,0.00427092133748341,-0.0231849101210433,-0.00644289847810833,0.000524898335359395
APOA2,Apolipoprotein A-II,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37433,-0.0660860420972163,0.00453490398374528,-0.0749744539053571,-0.0571976302890756,9.59991130000654e-48
APOA2,Apolipoprotein A-II,NMR metabolomics,X23465.Isoleucine,37443,-0.0589569831351306,0.00442278201675829,-0.0676256358879768,-0.0502883303822844,2.76292422612453e-40
APOA2,Apolipoprotein A-II,NMR metabolomics,X23466.Leucine,37444,-0.0571545560316588,0.0045608533530128,-0.0660938286035639,-0.0482152834597537,7.9171232515666e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23467.Valine,37433,-0.0684966174276514,0.0045190075058629,-0.0773538721391427,-0.0596393627161601,1.78410674699458e-51
APOA2,Apolipoprotein A-II,NMR metabolomics,X23468.Phenylalanine,37441,-0.036424253868027,0.00429786080946066,-0.0448480610545699,-0.0280004466814842,2.5915040044598e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23469.Tyrosine,37430,-0.0460318835738675,0.00441196206480047,-0.0546793292208764,-0.0373844379268585,2.17659791333517e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23470.Glucose,37424,-0.0159311820304202,0.00442283182652861,-0.0245999324104163,-0.00726243165042414,0.000316867859901377
APOA2,Apolipoprotein A-II,NMR metabolomics,X23471.Lactate,37421,0.00612549853474275,0.00434748788548198,-0.00239557772080193,0.0146465747902874,0.158865707363066
APOA2,Apolipoprotein A-II,NMR metabolomics,X23472.Pyruvate,37397,0.000207885883294773,0.00428652191330097,-0.00819369706677512,0.00860946883336467,0.961320418944032
APOA2,Apolipoprotein A-II,NMR metabolomics,X23473.Citrate,37444,0.0140736817876878,0.00439269915046946,0.00546399145276762,0.0226833721226079,0.00135901899778079
APOA2,Apolipoprotein A-II,NMR metabolomics,X23474.3-Hydroxybutyrate,37232,0.0396635146936443,0.00427358934226129,0.0312872795828122,0.0480397498044764,1.93239689878754e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23475.Acetate,37435,0.00552987396433268,0.0042963025407529,-0.002890879015543,0.0139506269442084,0.19807302902097
APOA2,Apolipoprotein A-II,NMR metabolomics,X23476.Acetoacetate,37445,-0.0171389442442632,0.00426135421571885,-0.0254911985070721,-0.00878668998145423,5.80310463222969e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23477.Acetone,37445,0.00832703851724504,0.00428190008170961,-6.54856429058003e-05,0.0167195626773959,0.0518309332570085
APOA2,Apolipoprotein A-II,NMR metabolomics,X23478.Creatinine,37096,0.0305279504749023,0.00542490445807347,0.0198951377370783,0.0411607632127262,1.86690133948481e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23479.Albumin,37444,0.0154402207704027,0.0043884708988255,0.00683881780870473,0.0240416237321007,0.000435641908464653
APOA2,Apolipoprotein A-II,NMR metabolomics,X23480.Glycoprotein Acetyls,37445,-0.0158642339362473,0.00460416578623917,-0.0248883988772761,-0.00684006899521853,0.000571460323788816
APOA2,Apolipoprotein A-II,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37445,-0.0903386199671214,0.00456173801948882,-0.0992796264853195,-0.0813976134489233,4.52266820074863e-86
APOA2,Apolipoprotein A-II,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37445,-0.093183209905898,0.00457918128041373,-0.102158405215509,-0.0842080145962871,1.05333325637932e-90
APOA2,Apolipoprotein A-II,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37445,-0.0892255821840481,0.00459155679133824,-0.098225033495071,-0.0802261308730251,5.46174251794987e-83
APOA2,Apolipoprotein A-II,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37445,-0.0814068405178753,0.00456500940588865,-0.0903542589534171,-0.0724594220823336,2.48659697928841e-70
APOA2,Apolipoprotein A-II,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37445,-0.0799306660903445,0.00457771689105111,-0.0889029911968047,-0.0709583409838844,1.55370623218557e-67
APOA2,Apolipoprotein A-II,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37445,-0.080434085790542,0.00453224003355801,-0.0893172762563157,-0.0715508953247683,1.10825925685536e-69
APOA2,Apolipoprotein A-II,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37445,-0.097780316092488,0.00456722676952597,-0.106732080560759,-0.0888285516242171,4.90058000006818e-100
APOA2,Apolipoprotein A-II,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37445,-0.0809077335671056,0.00464872959877077,-0.0900192435806963,-0.0717962235535149,4.08771486681712e-67
APOA2,Apolipoprotein A-II,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37445,-0.0849736897365438,0.00464872564051624,-0.0940851919919556,-0.075862187481132,9.30683992229574e-74
APOA2,Apolipoprotein A-II,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37445,-0.0866853451704405,0.0046179666046029,-0.0957365597154622,-0.0776341306254188,1.24074237500976e-77
APOA2,Apolipoprotein A-II,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37445,-0.07454524566769,0.00456317211934681,-0.0834890630216097,-0.0656014283137702,2.00593356957467e-59
APOA2,Apolipoprotein A-II,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37445,-0.0634570048020468,0.00453224801735926,-0.072340210916071,-0.0545737986880227,3.10899003680345e-44
APOA2,Apolipoprotein A-II,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37445,-0.0836541725749298,0.00458478891823861,-0.0926403588546775,-0.0746679862951821,1.67579069297935e-73
APOA2,Apolipoprotein A-II,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37445,-0.086251288077795,0.00469185925855555,-0.0954473322245639,-0.0770552439310261,1.43363341157768e-74
APOA2,Apolipoprotein A-II,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37445,-0.0716061251029382,0.00461025836490972,-0.0806422314981613,-0.0625700187077152,6.13440613127382e-54
APOA2,Apolipoprotein A-II,NMR metabolomics,X23496.Total Lipids in Large VLDL,37445,-0.0726166146881923,0.00461140932183305,-0.0816549769589851,-0.0635782524173995,2.21709221593974e-55
APOA2,Apolipoprotein A-II,NMR metabolomics,X23497.Phospholipids in Large VLDL,37445,-0.0764588798233558,0.00463430925880109,-0.0855421259706059,-0.0673756336761056,1.46019631415416e-60
APOA2,Apolipoprotein A-II,NMR metabolomics,X23498.Cholesterol in Large VLDL,37445,-0.0642280097094152,0.00453969521569546,-0.0731258123321783,-0.0553302070866521,4.01203004946966e-45
APOA2,Apolipoprotein A-II,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37445,-0.0549688285219985,0.00447277094627945,-0.0637354595767062,-0.0462021974672908,1.57018789848029e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37445,-0.0719142572752668,0.00461653427507622,-0.0809626644544162,-0.0628658500961174,3.04561539255728e-54
APOA2,Apolipoprotein A-II,NMR metabolomics,X23501.Triglycerides in Large VLDL,37445,-0.0731939460335979,0.00463587627472825,-0.0822802635320652,-0.0641076285351305,1.16436447637409e-55
APOA2,Apolipoprotein A-II,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37445,-0.029874019431275,0.00444165248058866,-0.0385796582932287,-0.0211683805693212,1.81516734919532e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37445,-0.0371746363711892,0.00445502497236475,-0.0459064853170241,-0.0284427874253543,7.84124116274053e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37445,-0.0298891675051699,0.00444242553013734,-0.0385963215442391,-0.0211820134661007,1.78754709150101e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37445,-0.00370483706506216,0.00449660360540565,-0.0125181801316572,0.00510850600153291,0.410000058393712
APOA2,Apolipoprotein A-II,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37445,0.0111689215681126,0.00454883744050394,0.00225320018472486,0.0200846429515003,0.0140877581914656
APOA2,Apolipoprotein A-II,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37445,-0.0208185230840565,0.00444485483998676,-0.0295304385704305,-0.0121066075976824,2.84422556158145e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37445,-0.0519704351673712,0.00455767780370879,-0.0609034836626404,-0.043037386672102,5.53979366978807e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37445,-0.0343935905311579,0.00445825427646095,-0.0431317689130214,-0.0256554121492944,1.29806375725634e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23510.Total Lipids in Small VLDL,37445,-0.0334428964237833,0.00444860485239424,-0.042162161934476,-0.0247236309130905,5.92741117571679e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23511.Phospholipids in Small VLDL,37445,-0.0223839995218417,0.004422932249145,-0.0310529467301659,-0.0137150523135175,4.22744943444147e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23512.Cholesterol in Small VLDL,37445,-0.0228780618048896,0.00443183655768397,-0.0315644614579502,-0.014191662151829,2.47498995473351e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37445,-0.029537431999659,0.00443661882323534,-0.0382332048932002,-0.0208416591061177,2.88937499323289e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37445,-0.0108529324272027,0.00443747723058045,-0.0195503877991403,-0.00215547705526498,0.0144679675330386
APOA2,Apolipoprotein A-II,NMR metabolomics,X23515.Triglycerides in Small VLDL,37445,-0.0397752771486231,0.00450346355948761,-0.0486020657252188,-0.0309484885720274,1.151252850856e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37445,-0.0365697019746363,0.00445853417198922,-0.0453084289517351,-0.0278309749975374,2.57129514673835e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37445,-0.0401769317717542,0.00444157579222824,-0.0488824203245216,-0.0314714432189869,1.68707988413741e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37445,-0.0498557306119335,0.0044056724904725,-0.0584908486932596,-0.0412206125306074,1.47843986240559e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37445,-0.0265267201707048,0.00461604978120349,-0.0355741777418636,-0.0174792625995459,9.29948271733904e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37445,-0.0214498290516799,0.00468006989436039,-0.0306227660446263,-0.0122768920587335,4.61931282399462e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37445,-0.0360954166995471,0.00447544308992563,-0.0448672851558013,-0.0273235482432929,7.91942914334823e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37445,-0.0408504919926892,0.00437658163463019,-0.0494285919965643,-0.032272391988814,1.17667203980838e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23523.Concentration of IDL Particles,37445,-0.0167563735880807,0.0045907718823409,-0.0257542864774689,-0.00775846069869255,0.00026321116206436
APOA2,Apolipoprotein A-II,NMR metabolomics,X23524.Total Lipids in IDL,37445,0.0127394855183355,0.00470377074348773,0.00352009486109952,0.0219588761755714,0.00677021302319544
APOA2,Apolipoprotein A-II,NMR metabolomics,X23525.Phospholipids in IDL,37445,0.00759061447132505,0.00470054863624467,-0.00162246085571451,0.0168036897983646,0.106369469606619
APOA2,Apolipoprotein A-II,NMR metabolomics,X23526.Cholesterol in IDL,37445,0.0209976210061918,0.00473161861138482,0.0117236485278775,0.030271593484506,9.16304866179186e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37445,0.0189180051415889,0.00472704413306286,0.00965299864078572,0.0281830116423921,6.31215593862328e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23528.Free Cholesterol in IDL,37445,0.0263444685930365,0.00472259618935829,0.0170881800618943,0.0356007571241788,2.4739662798894e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23529.Triglycerides in IDL,37445,-0.0375629122714856,0.00432143306664469,-0.0460329210821092,-0.029092903460862,3.95678540322497e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23530.Concentration of Large LDL Particles,37445,-0.00760052311937435,0.00448049326044716,-0.0163822899098508,0.00118124367110208,0.0898409060182223
APOA2,Apolipoprotein A-II,NMR metabolomics,X23531.Total Lipids in Large LDL,37445,0.0300290925097043,0.00449634383169463,0.0212162585995828,0.0388419264198257,2.50689665581957e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23532.Phospholipids in Large LDL,37445,0.0253017498502928,0.00451142977921358,0.0164593474830342,0.0341441522175514,2.08230035987851e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23533.Cholesterol in Large LDL,37445,0.0358391764122314,0.00450110627282076,0.0270170081175027,0.0446613447069601,1.82207908816298e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37445,0.032990390449386,0.00447690521839263,0.0242156562213364,0.0417651246774356,1.81809365598324e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37445,0.0431126160875388,0.0045723803107163,0.0341507506785349,0.0520744814965427,4.80449236309454e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23536.Triglycerides in Large LDL,37445,-0.0263355357106432,0.00434492078709252,-0.0348515804533446,-0.0178194909679419,1.38666276730455e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37445,-0.00567483017622823,0.00444451908389528,-0.014386087580663,0.00303642722820653,0.201689269931312
APOA2,Apolipoprotein A-II,NMR metabolomics,X23538.Total Lipids in Medium LDL,37445,0.00803886755174696,0.00442729130868822,-0.000638623413281959,0.0167163585167759,0.0694303024770812
APOA2,Apolipoprotein A-II,NMR metabolomics,X23539.Phospholipids in Medium LDL,37445,0.00934935757394387,0.00441985657407531,0.00068643868875626,0.0180122764591315,0.0344218651271076
APOA2,Apolipoprotein A-II,NMR metabolomics,X23540.Cholesterol in Medium LDL,37445,0.0108037129743458,0.00442774874802959,0.00212532542820777,0.0194821005204838,0.0146999028973315
APOA2,Apolipoprotein A-II,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37445,0.00137883804725518,0.00443431738943594,-0.00731242403603926,0.0100701001305496,0.755845622863188
APOA2,Apolipoprotein A-II,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37445,0.035839131057732,0.00442106470450042,0.0271738442369112,0.0445044178785528,5.65530557228942e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23543.Triglycerides in Medium LDL,37445,-0.0238965171758395,0.00440571130884666,-0.0325317113411789,-0.0152613230105,5.92820405567098e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23544.Concentration of Small LDL Particles,37445,-0.0178029523466525,0.00446419442821944,-0.0265527734259626,-0.00905313126734241,6.69977780821347e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23545.Total Lipids in Small LDL,37445,-0.00609822083948083,0.00446072881200786,-0.0148412493110162,0.00264480763205457,0.171619500562722
APOA2,Apolipoprotein A-II,NMR metabolomics,X23546.Phospholipids in Small LDL,37445,-0.00895026202514329,0.00447208210400285,-0.0177155429489889,-0.000184981101297707,0.0453730811900026
APOA2,Apolipoprotein A-II,NMR metabolomics,X23547.Cholesterol in Small LDL,37445,0.00150162390743369,0.00445322497627624,-0.00722669704606775,0.0102299448609351,0.735971948296105
APOA2,Apolipoprotein A-II,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37445,-0.00772770444640633,0.00445522041415082,-0.0164599364581419,0.00100452756532929,0.0828471286750345
APOA2,Apolipoprotein A-II,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37445,0.025769372224596,0.00443560059237868,0.0170755950635338,0.0344631493856582,6.3998746031974e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23550.Triglycerides in Small LDL,37445,-0.0440908263109918,0.00444978820575595,-0.0528124111942734,-0.0353692414277101,4.57699104121386e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37445,0.040939647815494,0.00521381473318528,0.0307205709384509,0.0511587246925372,4.39498977621208e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37445,0.0304335678670821,0.00523084103165886,0.0201811194450307,0.0406860162891334,6.08605406125477e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37445,0.0234992721811561,0.00516911119877217,0.0133678142315626,0.0336307301307495,5.51222685768728e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37445,0.0453716230210681,0.00531077728499328,0.0349624995424813,0.055780746499655,1.44197218948024e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37445,0.0624486369330183,0.00536400261380683,0.051935191809957,0.0729620820560797,3.53665914059068e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37445,-0.00890216527445387,0.00500515696176774,-0.0187122729195186,0.000907942370610896,0.0753279477228251
APOA2,Apolipoprotein A-II,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37445,-0.016612355285981,0.00424295680910778,-0.0249285506318323,-0.00829615994012977,9.07412343106913e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23558.Concentration of Large HDL Particles,37445,0.109464563841987,0.00526467235979078,0.0991458060167975,0.119783321667177,1.49871855697851e-94
APOA2,Apolipoprotein A-II,NMR metabolomics,X23559.Total Lipids in Large HDL,37445,0.0987190991525086,0.00519785803854816,0.0885312973969542,0.108906900908063,2.10528614625893e-79
APOA2,Apolipoprotein A-II,NMR metabolomics,X23560.Phospholipids in Large HDL,37445,0.0901203337932257,0.00509194660643405,0.0801401184446149,0.100100549141836,2.573934115388e-69
APOA2,Apolipoprotein A-II,NMR metabolomics,X23561.Cholesterol in Large HDL,37445,0.110549917649329,0.00531398894722072,0.100134499312777,0.120965335985882,1.19327002439072e-94
APOA2,Apolipoprotein A-II,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37445,0.118804640970468,0.00531259913098827,0.108391946673731,0.129217335267205,8.24434671860415e-109
APOA2,Apolipoprotein A-II,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37445,0.0813105270202769,0.00527520703127207,0.0709711212389837,0.0916499328015702,3.72834549287307e-53
APOA2,Apolipoprotein A-II,NMR metabolomics,X23564.Triglycerides in Large HDL,37445,0.00969949282526556,0.00427248059695868,0.00132543085522656,0.0180735547953046,0.0232095197091535
APOA2,Apolipoprotein A-II,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37445,0.108755812508389,0.00460954370298683,0.0997211068505351,0.117790518166243,1.17772803722924e-120
APOA2,Apolipoprotein A-II,NMR metabolomics,X23566.Total Lipids in Medium HDL,37445,0.0947617300580288,0.00455426306545461,0.0858353744497377,0.10368808566632,1.10745126700145e-94
APOA2,Apolipoprotein A-II,NMR metabolomics,X23567.Phospholipids in Medium HDL,37445,0.0762538733427261,0.00450061998285208,0.067432658176336,0.0850750885091162,9.77776159505476e-64
APOA2,Apolipoprotein A-II,NMR metabolomics,X23568.Cholesterol in Medium HDL,37445,0.123537364592281,0.00465759720773491,0.11440847406512,0.132666255119441,3.52053933344439e-151
APOA2,Apolipoprotein A-II,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37445,0.126917530254431,0.00464078641774227,0.117821588875656,0.136013471633206,2.39138687402357e-160
APOA2,Apolipoprotein A-II,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37445,0.105497039696354,0.00470309141937892,0.0962789805143712,0.114715098878337,1.86736609848344e-109
APOA2,Apolipoprotein A-II,NMR metabolomics,X23571.Triglycerides in Medium HDL,37445,-0.0327799949985245,0.00432547572958565,-0.0412579274285124,-0.0243020625685367,3.72576809308441e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23572.Concentration of Small HDL Particles,37445,0.0782216095484998,0.00424795741943829,0.0698956130064007,0.0865476060905988,8.2406130755735e-75
APOA2,Apolipoprotein A-II,NMR metabolomics,X23573.Total Lipids in Small HDL,37445,0.0575632629462439,0.0042947758925504,0.0491455021968451,0.0659810236956426,1.0517851506832e-40
APOA2,Apolipoprotein A-II,NMR metabolomics,X23574.Phospholipids in Small HDL,37445,0.0496019187116963,0.00430846655155305,0.0411573242706523,0.0580465131527403,1.5781410033101e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23575.Cholesterol in Small HDL,37445,0.0865839685791257,0.00422977217268913,0.078293615120655,0.0948743220375964,9.57437125414571e-92
APOA2,Apolipoprotein A-II,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37445,0.0870385527061328,0.00421007832536331,0.0787867991884207,0.0952903062238449,1.62841323940883e-93
APOA2,Apolipoprotein A-II,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37445,0.0733017773595495,0.00432070766300634,0.0648331903400571,0.0817703643790419,6.74873209477854e-64
APOA2,Apolipoprotein A-II,NMR metabolomics,X23578.Triglycerides in Small HDL,37445,-0.0559071903812514,0.00464261629340091,-0.0650067183163172,-0.0468076624461857,3.1484193131544e-33
APOA2,Apolipoprotein A-II,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36796,0.0211443463523361,0.00436465568820703,0.0125896212034503,0.0296990715012219,1.28435855367121e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36796,0.0646780213670533,0.00431062551092904,0.0562291953656324,0.0731268473684742,1.82714820779944e-50
APOA2,Apolipoprotein A-II,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36796,0.0513260335584407,0.00428634521612592,0.0429247969348339,0.0597272701820475,7.22631703555707e-33
APOA2,Apolipoprotein A-II,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36796,0.0735932064671928,0.00436717756414527,0.065033538441468,0.0821528744929175,4.80930344191231e-63
APOA2,Apolipoprotein A-II,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36796,-0.0550418002717733,0.00424198730893026,-0.0633560953972766,-0.0467275051462699,2.92006333449773e-38
APOA2,Apolipoprotein A-II,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37277,-0.0424606592131697,0.00420948550869024,-0.0507112508102026,-0.0342100676161369,7.67772277415625e-24
APOA2,Apolipoprotein A-II,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37277,0.0569619639682833,0.0047197112653455,0.0477113298882062,0.0662125980483605,2.29381416368354e-33
APOA2,Apolipoprotein A-II,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37277,0.0647841563881831,0.00469214844908868,0.0555875454279693,0.0739807673483969,4.55947516436213e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37277,0.0132701470670876,0.00452515186219116,0.00440084941719289,0.0221394447169822,0.0033677981303528
APOA2,Apolipoprotein A-II,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37277,-0.0343370370865102,0.00459013481424,-0.0433337013224206,-0.0253403728505998,7.85690560257306e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37441,-0.0576829045873512,0.00457726645146579,-0.0666543468322241,-0.0487114623424782,3.28037818747858e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37441,0.0304764530322427,0.00441371315780108,0.0218255752429525,0.0391273308215328,5.24544343193789e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37441,0.0432397356969556,0.00460130118278134,0.0342211853787041,0.052258286015207,6.48010999383386e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37441,-0.00213213882528645,0.00431023198305159,-0.0105801935120676,0.00631591586149468,0.620841677693521
APOA2,Apolipoprotein A-II,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37441,-0.000476738464790559,0.00424244166516326,-0.00879192412851054,0.00783844719892942,0.910528843540046
APOA2,Apolipoprotein A-II,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37445,0.0232860282517379,0.00465591188899768,0.0141604409493024,0.0324116155541733,5.76291686793097e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37445,0.0517202154283931,0.00484444824226539,0.042225096873553,0.0612153339832333,1.67579629899243e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37445,0.0547372956990776,0.00485904247143381,0.0452135724550673,0.0642610189430878,2.63362123274434e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37445,0.041748299768031,0.00475396703572829,0.0324305243780035,0.0510660751580584,1.79947819109795e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37445,-0.0460746410224438,0.00481608295811772,-0.0555141636203545,-0.0366351184245331,1.28949344871434e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37445,0.0399992968089006,0.00463247199776078,0.0309196516932895,0.0490789419245118,6.54641136727996e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37445,0.0154107142231057,0.0044775198979019,0.00663477522321801,0.0241866532229935,0.000579603534580512
APOA2,Apolipoprotein A-II,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37445,-0.0046983672214266,0.00434872672142475,-0.0132218715954191,0.00382513715256591,0.279982981573337
APOA2,Apolipoprotein A-II,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37445,0.0439057020633521,0.00466534926942574,0.0347616174952777,0.0530497866314266,5.69121968829467e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37445,-0.0229987640965152,0.0045260401447814,-0.0318698027802868,-0.0141277254127437,3.79574074181512e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37445,-0.0935919808972803,0.00445701676392041,-0.102327733754564,-0.0848562280399963,2.26929927883386e-96
APOA2,Apolipoprotein A-II,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37445,0.0332336401155631,0.00476652724854676,0.0238912467084115,0.0425760335227147,3.26211890650413e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37445,0.0354343753241271,0.00481960934193106,0.0259879410139423,0.044880809634312,2.06231539173291e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37445,0.0103729195562813,0.00433820859826973,0.00187003070367264,0.01887580840889,0.0168133073498563
APOA2,Apolipoprotein A-II,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37445,-0.0124435103138126,0.00472498952655025,-0.0217044897858511,-0.00318253084177416,0.0084592368189
APOA2,Apolipoprotein A-II,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37445,-0.0319322099252195,0.00436439420020492,-0.0404864225576211,-0.0233779972928178,2.68736245999794e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37445,0.0506877930163382,0.00456271127706631,0.0417448789132883,0.0596307071193882,1.50305580077709e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37445,0.0336477426827731,0.00452314278650531,0.0247823828212227,0.0425131025443236,1.07517097525412e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37445,0.057065523490334,0.00444403276724971,0.0483552192665246,0.0657758277141434,1.59810413608955e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37445,-0.0495781577586039,0.00460706296639278,-0.0586080011727338,-0.0405483143444741,6.72636708092668e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37445,-0.038101855599944,0.00435803686498139,-0.0466436078553076,-0.0295601033445805,2.53610397123758e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37445,0.0855666441060687,0.00453077453773068,0.0766863260121165,0.0944469622000208,1.51357265672938e-78
APOA2,Apolipoprotein A-II,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37445,0.0500607371548483,0.00428914825824876,0.0416540065686808,0.0584674677410159,2.51528545287953e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37445,0.0617359811406184,0.00481743987473314,0.0522937989861414,0.0711781632950953,2.22148144678432e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37445,-0.0583457772090282,0.00445421111643374,-0.0670760309972383,-0.0496155234208181,5.74416446948718e-39
APOA2,Apolipoprotein A-II,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37445,0.00713275038560937,0.00431911884897839,-0.00133272255838827,0.015598223329607,0.0986725959489333
APOA2,Apolipoprotein A-II,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37445,0.0397581932845183,0.00448151401436299,0.0309744258163668,0.0485419607526698,8.10064331980444e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37445,-0.0460417090330337,0.00445259014748652,-0.0547687857221073,-0.0373146323439601,5.7233625178867e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37445,0.0817695688906949,0.00464535882750145,0.0726646655887921,0.0908744721925978,1.36028273106974e-68
APOA2,Apolipoprotein A-II,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37445,-0.0383949420042108,0.00436298435513828,-0.0469463913402818,-0.0298434926681397,1.52936902673328e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37445,-0.0090577669774165,0.00442171103970078,-0.01772432061523,-0.000391213339602963,0.0405326008204433
APOA2,Apolipoprotein A-II,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37445,0.0560959925184544,0.00432299877732413,0.0476229149148991,0.0645690701220097,2.81941472045823e-38
APOA2,Apolipoprotein A-II,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37445,-0.0128870977353698,0.00442989442793273,-0.0215696908141179,-0.00420450465662161,0.00363034448862024
APOA2,Apolipoprotein A-II,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37445,0.0658630955240705,0.00443606202448703,0.0571684139560759,0.074557777092065,1.77117682488166e-49
APOA2,Apolipoprotein A-II,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37445,-0.0482639911337781,0.00447480907833349,-0.0570346169273117,-0.0394933653402444,5.17312412659185e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37440,-0.00500889139628329,0.00489509603676001,-0.0146032796283329,0.00458549683576632,0.306209393483017
APOA2,Apolipoprotein A-II,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37440,0.0358588863092913,0.00448698266048512,0.0270644002947404,0.0446533723238421,1.4370134027103e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37440,0.100941104940651,0.00420712489220159,0.0926951401519358,0.109187069729366,1.27123242838662e-124
APOA2,Apolipoprotein A-II,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37440,-0.0903517988153646,0.00511600443289604,-0.100379167503841,-0.0803244301268883,4.97586632825469e-69
APOA2,Apolipoprotein A-II,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37440,-0.0339283862893011,0.00481020022582408,-0.0433563787319163,-0.0245003938466859,1.83016137648692e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37445,-0.0824477374477711,0.00479502678715799,-0.0918459899506008,-0.0730494849449415,1.44262369508907e-65
APOA2,Apolipoprotein A-II,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37445,0.0921425195866087,0.00488434993309889,0.0825691937177349,0.101715845455482,2.22162056428091e-78
APOA2,Apolipoprotein A-II,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37445,0.103772909987748,0.00469090281943231,0.0945787404616607,0.112967079513835,1.45745016281023e-106
APOA2,Apolipoprotein A-II,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37445,-0.031697659217838,0.00484974812039506,-0.0412031655338124,-0.0221921529018637,6.54674936045668e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37445,-0.0646002875082497,0.00464697726664199,-0.073708362950868,-0.0554922120656314,1.23280052163229e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37445,-0.179028595574361,0.00463605203715175,-0.188115257567178,-0.169941933581543,1.69950358025406e-308
APOA2,Apolipoprotein A-II,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37445,0.136406089490659,0.00463925721213063,0.127313145354883,0.145499033626435,2.82818722299252e-184
APOA2,Apolipoprotein A-II,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37445,0.118845891616902,0.0044540539369782,0.110115945900424,0.127575837333379,6.31470167845451e-153
APOA2,Apolipoprotein A-II,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37445,0.112251630125956,0.00507332157834065,0.102307919832408,0.122195340419503,1.34639997103757e-106
APOA2,Apolipoprotein A-II,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37445,-0.0966303484995088,0.00457151627000573,-0.10559052038872,-0.0876701766102976,1.33143123017539e-97
APOA2,Apolipoprotein A-II,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37445,-0.0413010014720754,0.00428912209585104,-0.0497076807799435,-0.0328943221642074,7.06734457140955e-22
APOA2,Apolipoprotein A-II,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37445,0.0842221605971105,0.0042497140881771,0.0758927209842834,0.0925516002099376,3.40142808754414e-86
APOA2,Apolipoprotein A-II,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37445,0.0693034093349798,0.00418568916689455,0.0610994585678665,0.0775073601020931,5.61383656555835e-61
APOA2,Apolipoprotein A-II,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37445,0.0500923278671015,0.00470647447931035,0.0408676378876532,0.0593170178465498,2.38004434738623e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37445,-0.099088467348974,0.00467940719969684,-0.10826010546038,-0.0899168292375682,6.10962450133013e-98
APOA2,Apolipoprotein A-II,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48073,0.00257533823348263,0.00363538435699657,-0.00455001510623064,0.0097006915731959,0.47869825508198
APOA2,Apolipoprotein A-II,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48073,0.00285106145797838,0.00356036996970379,-0.00412726368264106,0.00982938659859781,0.423268764101468
APOA2,Apolipoprotein A-II,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46298,0.000253131809190615,0.0034133035822152,-0.00643694321195118,0.00694320683033241,0.940883451264821
APOA2,Apolipoprotein A-II,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46298,-0.00153685496278958,0.00369620946069035,-0.00878142550574266,0.00570771558016351,0.67756606322138
APOA2,Apolipoprotein A-II,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46298,0.00196468681544243,0.0036692003236872,-0.00522694581898448,0.00915631944986934,0.592341486278289
APOA2,Apolipoprotein A-II,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46298,-0.00232972587253878,0.00338757636306396,-0.00896937554414413,0.00430992379906658,0.4916321680082
APOA2,Apolipoprotein A-II,Working and living environment,X24009.Traffic intensity on the nearest road,48073,0.0379694719653396,0.0532090520191985,-0.0663202699922895,0.142259213922969,0.475487335853412
APOA2,Apolipoprotein A-II,Working and living environment,X24010.Inverse distance to the nearest road,48073,0.00178902983772205,0.00318375265906013,-0.0044511253740358,0.0080291850494799,0.574172401351102
APOA2,Apolipoprotein A-II,Working and living environment,X24011.Traffic intensity on the nearest major road,48073,-0.00422995409173206,0.00321379977385978,-0.0105290016484972,0.00206909346503311,0.188124517278895
APOA2,Apolipoprotein A-II,Working and living environment,X24012.Inverse distance to the nearest major road,48073,0.000166326930783402,0.00326285163842749,-0.00622886228053449,0.00656151614210129,0.959345112855763
APOA2,Apolipoprotein A-II,Working and living environment,X24013.Total traffic load on major roads,48073,0.0380631088658517,0.0367982641324882,-0.0340614888338253,0.110187706565529,0.300972432146325
APOA2,Apolipoprotein A-II,Working and living environment,X24015.Sum of road length of major roads within 100m,48073,0.0622429758573765,0.0358293272575691,-0.00798250556745893,0.132468457282212,0.0823632690863371
APOA2,Apolipoprotein A-II,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48073,0.00384809754499736,0.00364980543050501,-0.00330552109879247,0.0110017161887872,0.291742606279024
APOA2,Apolipoprotein A-II,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48073,0.002918592296216,0.00364945297677809,-0.00423433553826906,0.0100715201307011,0.423872668729719
APOA2,Apolipoprotein A-II,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48073,0.00327748534623969,0.00361192892261265,-0.0038018953420811,0.0103568660345605,0.364201260359765
APOA2,Apolipoprotein A-II,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48026,0.00179614638182221,0.0034943306305264,-0.00505274165400954,0.00864503441765396,0.607244598252416
APOA2,Apolipoprotein A-II,Working and living environment,X24020.Average daytime sound level of noise pollution,48073,0.00120715350837822,0.00319428092561727,-0.00505363710583162,0.00746794412258806,0.705500114098412
APOA2,Apolipoprotein A-II,Working and living environment,X24021.Average evening sound level of noise pollution,48073,0.00123929334768125,0.00319401432684324,-0.0050209747329315,0.00749956142829399,0.6980157864214
APOA2,Apolipoprotein A-II,Working and living environment,X24022.Average night-time sound level of noise pollution,48073,0.00118859595194266,0.00319435863856546,-0.00507234697964564,0.00744953888353095,0.709827455594423
APOA2,Apolipoprotein A-II,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48073,0.00123665948438666,0.00319423439487985,-0.00502403992957786,0.00749735889835117,0.698645868952953
APOA2,Apolipoprotein A-II,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48073,0.00123365512266692,0.00319437482026393,-0.00502731952505038,0.00749462977038422,0.699354829376448
APOA2,Apolipoprotein A-II,Health and medical history,X2405.Number of children fathered,34677,-0.111003988134588,0.0387584035279778,-0.186970459049424,-0.0350375172197513,0.00419135566435806
APOA2,Apolipoprotein A-II,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45175,-0.0055876199712168,0.0037848100273324,-0.0130058476247883,0.0018306076823547,0.139870707739313
APOA2,Apolipoprotein A-II,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45175,0.00664702626963823,0.00345412350429617,-0.000123055798782253,0.0134171083380587,0.0543209884753486
APOA2,Apolipoprotein A-II,Working and living environment,"X24502.Water percentage, buffer 1000m",45175,-1.23782327945735e-05,0.00336203853824151,-0.00660197376774794,0.00657721730215879,0.997062418359361
APOA2,Apolipoprotein A-II,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45175,-0.00351534765117085,0.00357853889190901,-0.0105292838793125,0.00349858857697081,0.325942732330716
APOA2,Apolipoprotein A-II,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45175,0.00230675334718805,0.00350730933935203,-0.00456757295794192,0.00918107965231802,0.51073875868032
APOA2,Apolipoprotein A-II,Working and living environment,"X24505.Water percentage, buffer 300m",45175,0.0039450405470985,0.00338035551573768,-0.00268045626374735,0.0105705373579444,0.243203635013158
APOA2,Apolipoprotein A-II,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48164,-0.00283177118103241,0.00358211418176412,-0.00985271497729009,0.00418917261522527,0.429225622214617
APOA2,Apolipoprotein A-II,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48164,-0.00403618766659409,0.0033793939640657,-0.0106597998361629,0.00258742450297468,0.232351760870927
APOA2,Apolipoprotein A-II,Working and living environment,X24508.Distance (Euclidean) to coast,48164,0.00287281941319531,0.00323177466808505,-0.00346145893625139,0.00920709776264201,0.374049838804303
APOA2,Apolipoprotein A-II,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28110,-0.0346791787718592,0.0629474935061057,-0.158056266043826,0.0886979085001081,0.581715888705385
APOA2,Apolipoprotein A-II,Health and medical history,X2704.Years since last cervical smear test,34087,0.0702787455078106,0.0382805405438802,-0.00475111395819457,0.145308604973816,0.0664033904989937
APOA2,Apolipoprotein A-II,Health and medical history,X2714.Age when periods started (menarche),37020,0.00412066262493999,0.0337082254619184,-0.0619474592804201,0.0701887845303,0.902706841242063
APOA2,Apolipoprotein A-II,Health and medical history,X2734.Number of live births,37436,-0.097073599273939,0.032234017300656,-0.160252273183225,-0.0338949253646532,0.0026041624627141
APOA2,Apolipoprotein A-II,Health and medical history,X2744.Birth weight of first child,34060,0.01469850656759,0.0371191344498241,-0.0580549969540654,0.0874520100892453,0.692126646358299
APOA2,Apolipoprotein A-II,Health and medical history,X2754.Age at first live birth,32284,-0.00358867495798239,0.00526449501163358,-0.0139070851807842,0.00672973526481944,0.495463178104502
APOA2,Apolipoprotein A-II,Health and medical history,X2764.Age at last live birth,32260,-0.0111821054058446,0.00525713231169001,-0.0214860847367571,-0.000878126074932222,0.0334462138302851
APOA2,Apolipoprotein A-II,Health and medical history,X2794.Age started oral contraceptive pill,35429,0.00571133866920729,0.00519173540747043,-0.00446446272943475,0.0158871400678493,0.271318947916884
APOA2,Apolipoprotein A-II,Health and medical history,X2804.Age when last used oral contraceptive pill,34378,-0.0128675480861285,0.0046071359108497,-0.0218975344713939,-0.00383756170086313,0.00523224473260341
APOA2,Apolipoprotein A-II,Lifestyle factors,X2867.Age started smoking in former smokers,28654,0.00505617083150366,0.00717168192749568,-0.00900032574638787,0.0191126674093952,0.480832766055226
APOA2,Apolipoprotein A-II,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34473,-0.0200285054118063,0.0441701239013259,-0.106601948258405,0.0665449374347925,0.650241139107331
APOA2,Apolipoprotein A-II,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34469,-0.0568006400483258,0.0487315050197574,-0.15231438988705,0.0387131097903987,0.243809076144755
APOA2,Apolipoprotein A-II,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34487,-0.077631348581648,0.0501956586973256,-0.176014839628406,0.0207521424651101,0.121995555582477
APOA2,Apolipoprotein A-II,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34459,-0.0846637429952323,0.0491337077351208,-0.180965810156069,0.0116383241656045,0.0848942747617245
APOA2,Apolipoprotein A-II,Mental health,X28739.Difficulty with standing for long periods,34503,0.0497906881285098,0.0458295088408104,-0.0400351491994785,0.139616525456498,0.277312105821064
APOA2,Apolipoprotein A-II,Mental health,X28740.Difficulty with taking care of household responsibilities,34521,-0.0658592576431745,0.0510047014052233,-0.165828472397412,0.0341099571110631,0.196648833163195
APOA2,Apolipoprotein A-II,Mental health,X28741.Difficulty learning a new task,34440,-0.0622675600168649,0.057806640557023,-0.17556857550863,0.0510334554749001,0.281429038706837
APOA2,Apolipoprotein A-II,Mental health,X28742.Difficulty with joining in community activities,34058,0.0824529313597417,0.0556295281493161,-0.0265809438129178,0.191486806532401,0.138323518464393
APOA2,Apolipoprotein A-II,Mental health,X28743.Difficulty with being emotionally affected by health problems,34444,-0.0322028552611788,0.0475710639560924,-0.12544214061512,0.0610364300927622,0.498457498847919
APOA2,Apolipoprotein A-II,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,34517,-0.0603722316305419,0.0647918356400359,-0.187364229485012,0.0666197662239284,0.351467397465893
APOA2,Apolipoprotein A-II,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,28520,0.0872996768323507,0.0584551958518522,-0.0272725070372795,0.201871860701981,0.135388202506422
APOA2,Apolipoprotein A-II,Lifestyle factors,X2897.Age stopped smoking,28657,-0.0101372649343547,0.00857052691791042,-0.0269354976934591,0.00666096782474976,0.23694492617619
APOA2,Apolipoprotein A-II,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,33327,0.0140809514403961,0.010268039167329,-0.00604440532756875,0.0342063082083609,0.170302143677691
APOA2,Apolipoprotein A-II,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,33327,-0.0187615900893809,0.0110107058553538,-0.0403425735658743,0.00281939338711251,0.0884249790073579
APOA2,Apolipoprotein A-II,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,33327,-0.00589285886650129,0.0372764681105809,-0.0789547363632399,0.0671690186302373,0.874393014252764
APOA2,Apolipoprotein A-II,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,33327,0.0412041295727615,0.0370089203159078,-0.0313333542464179,0.113741613391941,0.265583529025042
APOA2,Apolipoprotein A-II,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,33327,0.0279271701293495,0.0388631758604104,-0.048244654557055,0.104098994815754,0.472403689855856
APOA2,Apolipoprotein A-II,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,33327,0.0100025232605045,0.0334041478193732,-0.055469606465467,0.0754746529864759,0.76461125643658
APOA2,Apolipoprotein A-II,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,33327,-0.0239543374604466,0.0152813858767289,-0.0539058537788352,0.00599717885794195,0.117019594871156
APOA2,Apolipoprotein A-II,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,33327,-0.0197022723216779,0.027705765398756,-0.0740055725032397,0.0346010278598838,0.477024077685442
APOA2,Apolipoprotein A-II,Mental health,X29002.Recent lack of interest or pleasure in doing things,33267,-0.0372861558520333,0.0509072990100511,-0.137064461911733,0.0624921502076669,0.463922933159278
APOA2,Apolipoprotein A-II,Mental health,X29003.Recent feelings of depression,33265,-0.0486496313940571,0.0493378439268537,-0.14535180549069,0.0480525427025763,0.324133447772201
APOA2,Apolipoprotein A-II,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",33273,-0.0365184574693655,0.0405709001016872,-0.116037421668672,0.0430005067299415,0.368082325620129
APOA2,Apolipoprotein A-II,Mental health,X29005.Recent feelings of tiredness or low energy,33278,-0.0663642999067469,0.0412255672857299,-0.147166411786777,0.0144378119732837,0.107478322076802
APOA2,Apolipoprotein A-II,Mental health,X29006.Recent poor appetite or overeating,33281,0.0130949931444835,0.0537132563805501,-0.0921829893613947,0.118372975650362,0.807395337927955
APOA2,Apolipoprotein A-II,Mental health,X29007.Recent feelings of inadequacy,33247,0.0247452266809718,0.0528105909205465,-0.0787635315232993,0.128253984885243,0.639391047174908
APOA2,Apolipoprotein A-II,Mental health,X29008.Recent trouble concentrating on things,33278,-0.0831819035118078,0.0529888795344188,-0.187040107399269,0.0206763003756529,0.116495422481492
APOA2,Apolipoprotein A-II,Mental health,X29009.Recent changes in speed or amount of moving or speaking,33269,-0.0423423824002557,0.093451765970625,-0.225507843702681,0.140823078902169,0.650491906866151
APOA2,Apolipoprotein A-II,Mental health,X29010.Recent thoughts of suicide or self-harm,33215,0.0453549520142522,0.101413137633531,-0.153414797747468,0.244124701775973,0.654719683206701
APOA2,Apolipoprotein A-II,Mental health,X29038#0.Substances taken for depression_None of options listed,31586,-0.0142584621087765,0.0199053157362438,-0.0532728809518143,0.0247559567342612,0.473818955551627
APOA2,Apolipoprotein A-II,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31586,0.0404731349995391,0.0346071900745231,-0.0273569575465262,0.108303227545604,0.242238014450232
APOA2,Apolipoprotein A-II,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31586,-0.0173382214270283,0.0197514842661732,-0.0560511305887278,0.0213746877346712,0.380069433290423
APOA2,Apolipoprotein A-II,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31586,0.0784106280720238,0.0566318601665407,-0.0325878178543961,0.189409073998444,0.166224766070498
APOA2,Apolipoprotein A-II,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31586,-0.0146836740181817,0.0339559559373963,-0.0812373476554783,0.051869999619115,0.665438847401195
APOA2,Apolipoprotein A-II,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31586,0.0171123700286327,0.0365540436122475,-0.0545335554513724,0.0887582955086379,0.639698463200971
APOA2,Apolipoprotein A-II,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31586,-0.0240493592973317,0.0428577385437932,-0.108050526843166,0.059951808248503,0.574715705574292
APOA2,Apolipoprotein A-II,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31586,0.0480887734937061,0.0497619269729267,-0.0494446033732303,0.145622150360643,0.33388589933157
APOA2,Apolipoprotein A-II,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31586,0.034652602189672,0.0395601398003092,-0.0428852718189341,0.112190476198278,0.381085853739173
APOA2,Apolipoprotein A-II,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31586,-0.0262200413680991,0.0201346377676791,-0.0656839313927502,0.013243848656552,0.192874690611993
APOA2,Apolipoprotein A-II,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31586,-0.0253025876299675,0.0296248490935654,-0.0833672918533557,0.0327621165934206,0.393075989670972
APOA2,Apolipoprotein A-II,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31586,-0.140337913358984,0.046447512215622,-0.231375037301603,-0.0493007894163651,0.00252407334817577
APOA2,Apolipoprotein A-II,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31586,-0.139976555792167,0.0569670211206317,-0.251631917188605,-0.0283211943957287,0.0140262128151372
APOA2,Apolipoprotein A-II,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31586,-0.039765428864768,0.0365654584039451,-0.1114337273365,0.0319028696069644,0.276843870070783
APOA2,Apolipoprotein A-II,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31586,0.00416100205006344,0.0593777972415572,-0.112219480543389,0.120541484643516,0.944134399102679
APOA2,Apolipoprotein A-II,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31586,-0.0954259543665033,0.0555718283757323,-0.204346737982939,0.013494829249932,0.0859892509866595
APOA2,Apolipoprotein A-II,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31586,-0.0339354638351675,0.0306892085708617,-0.0940863126340565,0.0262153849637215,0.268856879201746
APOA2,Apolipoprotein A-II,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31586,-0.0312866412688665,0.0300534549742534,-0.0901914130184032,0.0276181304806703,0.297892763669624
APOA2,Apolipoprotein A-II,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31586,-0.0735681326534516,0.0429334285129323,-0.157717652538799,0.0105813872318958,0.0866534177891263
APOA2,Apolipoprotein A-II,Mental health,X29058.Recent feelings or nervousness or anxiety,33127,-0.0330358866286732,0.0473030105239311,-0.125749787255578,0.0596780139982318,0.484951687979735
APOA2,Apolipoprotein A-II,Mental health,X29059.Recent inability to stop or control worrying,33132,-0.0316183680600729,0.0494295355691138,-0.128500257775536,0.06526352165539,0.522405903539825
APOA2,Apolipoprotein A-II,Mental health,X29060.Recent worrying too much about different things,33124,-0.01017242037706,0.0454448910338689,-0.099244406803443,0.0788995660493231,0.822886125164915
APOA2,Apolipoprotein A-II,Mental health,X29061.Recent trouble relaxing,33131,-0.0420904208257163,0.0477321419667973,-0.135645419080639,0.0514645774292064,0.377905366903276
APOA2,Apolipoprotein A-II,Mental health,X29062.Recent restlessness,33132,-0.0800993889923248,0.0664504301552965,-0.210342232096706,0.0501434541120563,0.228079454626284
APOA2,Apolipoprotein A-II,Mental health,X29063.Recent easy annoyance or irritability,33117,-0.0390253574612812,0.048104689965345,-0.133310549793357,0.0552598348707949,0.417237874377975
APOA2,Apolipoprotein A-II,Mental health,X29064.Recent feelings of foreboding,33110,-0.0823392786537922,0.0549620690569408,-0.190064934005396,0.0253863766978118,0.13413855149157
APOA2,Apolipoprotein A-II,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31586,-0.040241845377761,0.0203282705280722,-0.0800852556127826,-0.000398435142739378,0.0477839218228163
APOA2,Apolipoprotein A-II,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31586,-0.0475493571445946,0.0329358349541736,-0.112103593654775,0.0170048793655856,0.148864848373002
APOA2,Apolipoprotein A-II,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31586,0.0318905715571926,0.0436398104658446,-0.0536434569558628,0.117424600070248,0.464943108617388
APOA2,Apolipoprotein A-II,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31586,-0.0155557216136148,0.0481936709414721,-0.1100153166589,0.0789038734316705,0.746874233110199
APOA2,Apolipoprotein A-II,Mental health,X29065#2.Symptoms of panic attack_Sweating,31586,-0.0185645779866133,0.0306899529637633,-0.0787168857955894,0.0415877298223628,0.545258327297517
APOA2,Apolipoprotein A-II,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31586,-0.00499809112102953,0.0330775961338895,-0.0698301795434529,0.0598339973013939,0.879899195202815
APOA2,Apolipoprotein A-II,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31586,-0.00569065961400681,0.0330191023193118,-0.0704081001598579,0.0590267809318443,0.8631712413053
APOA2,Apolipoprotein A-II,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31586,-0.0386982159563281,0.0303954024303176,-0.0982732047197507,0.0208767728070944,0.202999514500694
APOA2,Apolipoprotein A-II,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31586,-0.0633114235216724,0.0402723640095533,-0.142245256980397,0.0156224099370521,0.115972685344085
APOA2,Apolipoprotein A-II,Mental health,X29076.Felt loved as a child,33091,0.0110024498144747,0.0422055239570608,-0.0717203771413644,0.0937252767703137,0.794339372751711
APOA2,Apolipoprotein A-II,Mental health,X29077.Physically abused by family as a child,33095,0.0209101211307397,0.0543658470164,-0.0856469390214044,0.127467181282884,0.700528800465186
APOA2,Apolipoprotein A-II,Mental health,X29078.Felt hated by family member as a child,33082,0.0655447197502518,0.0551410823270679,-0.0425318016108013,0.173621241111305,0.234598958754723
APOA2,Apolipoprotein A-II,Mental health,X29079.Sexually molested as a child,33017,0.0568929504817326,0.0759793170363635,-0.0920265109095398,0.205812411873005,0.453999871971311
APOA2,Apolipoprotein A-II,Mental health,X29080.Someone to take to doctor when needed as a child,33081,-0.0059415952525368,0.0632160779474861,-0.12984510802961,0.117961917524536,0.925120197613217
APOA2,Apolipoprotein A-II,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,33079,0.115152584616698,0.0762597618363741,-0.0343165485825954,0.264621717815991,0.131076547617913
APOA2,Apolipoprotein A-II,Mental health,X29082.Belittlement by partner or ex-partner as an adult,33032,-0.0190871142777946,0.0599153683075996,-0.13652123616069,0.0983470076051006,0.750061437169528
APOA2,Apolipoprotein A-II,Mental health,X29083.Physical violence by partner or ex-partner as an adult,33086,-0.0249748633164875,0.0661206212510875,-0.154571280968619,0.104621554335644,0.705649745253873
APOA2,Apolipoprotein A-II,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,33054,-0.0501852248611522,0.093830127096713,-0.23409227397071,0.133721824248405,0.592765184209841
APOA2,Apolipoprotein A-II,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,33054,0.0986568699014717,0.090966043216207,-0.0796365748022941,0.276950314605237,0.278151167603354
APOA2,Apolipoprotein A-II,Mental health,X29086.Experienced a violent or sexual assault,33088,0.15015221184146,0.0725618492197322,0.00793098737078513,0.292373436312135,0.0385457476301441
APOA2,Apolipoprotein A-II,Mental health,X29087.Experienced a life-threatening injury or illness,33096,-0.023154678818071,0.0509808464883895,-0.123077137935314,0.0767677802991725,0.649707156151597
APOA2,Apolipoprotein A-II,Mental health,X29088.Experienced a marital separation or divorce,33097,-0.0497413818877641,0.0459609003352776,-0.139824746544908,0.0403419827693801,0.279167802342163
APOA2,Apolipoprotein A-II,Mental health,X29089.Experienced the death of a spouse or partner,33106,0.0296159055276754,0.0723559509364739,-0.112201758307814,0.171433569363164,0.682322762806153
APOA2,Apolipoprotein A-II,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,33093,-0.0200260858584021,0.056992131536976,-0.131730663670875,0.0916784919540708,0.725308793819312
APOA2,Apolipoprotein A-II,Lifestyle factors,X29091.Frequency of drinking alcohol,33100,0.160230901298291,0.0389634727488261,0.0838624947105919,0.23659930788599,3.95069016997535e-05
APOA2,Apolipoprotein A-II,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,32143,0.16309413795732,0.0431205292200567,0.0785779006860089,0.247610375228631,0.000156489291113997
APOA2,Apolipoprotein A-II,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,32156,0.236505117359601,0.0435418303588046,0.151163129856344,0.321847104862858,5.74084277713515e-08
APOA2,Apolipoprotein A-II,Mental health,X29104.Ever used cannabis,33090,0.113751933814417,0.0508027594058993,0.0141785253788542,0.213325342249979,0.0251738180543207
APOA2,Apolipoprotein A-II,Mental health,X29108.Ever thought that life not worth living,33049,0.0285129565237781,0.0464531565088156,-0.0625352302335006,0.119561143281057,0.53936256415967
APOA2,Apolipoprotein A-II,Mental health,X29109.Ever contemplated self-harm,33062,0.0538001757680186,0.0606986262622279,-0.0651691317059481,0.172769483241985,0.375452576684937
APOA2,Apolipoprotein A-II,Mental health,X29111.Ever self-harmed,33081,0.076995260332044,0.0950682010895428,-0.10933841380346,0.263328934467548,0.418021429582924
APOA2,Apolipoprotein A-II,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,33088,0.0386267261052308,0.0645954725397589,-0.0879804000726966,0.165233852283158,0.549868724604316
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,32126,-0.0146448254499244,0.0415222084765487,-0.0960283540639598,0.066738703164111,0.724323389937548
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,32126,-0.0612366855402405,0.032973507578044,-0.125864760393207,0.00339138931272578,0.0633256362911646
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,32126,-0.0374879568754726,0.0341476709870457,-0.104417392010082,0.029441478259137,0.27231557631002
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,32126,-0.0374150174408633,0.0452928139917741,-0.126188932864741,0.0513588979830139,0.408788444229683
APOA2,Apolipoprotein A-II,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,33079,0.0590918144813226,0.0429292904076944,-0.0250495947177584,0.143233223680404,0.16870287007423
APOA2,Apolipoprotein A-II,Health and medical history,X29153.Pain or discomfort today,33090,-0.000345014330829507,0.0412947854621247,-0.0812827938365939,0.0805927651749349,0.993334002262587
APOA2,Apolipoprotein A-II,Mental health,X29154.Anxiety or depression today,33090,-0.109312361396542,0.0504814593022665,-0.208256021628985,-0.0103687011640999,0.0303828961709374
APOA2,Apolipoprotein A-II,Mental health,X29166.Frequency of confiding in someone close,32883,-0.0410349759370294,0.0400783389498265,-0.119588520278689,0.0375185684046306,0.305924531031421
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,33062,-0.00340028922644121,0.0106853677984544,-0.0243436101114119,0.0175430316585295,0.750325888643935
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,33062,0.0110756475683259,0.0106394065268767,-0.00977758922435239,0.0319288843610041,0.297901790939766
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,33062,-0.00414160885943693,0.013334985838993,-0.0302781811038633,0.0219949633849894,0.756125316601192
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,33062,-0.0270311538268479,0.0156906988730819,-0.0577849236180885,0.00372261596439264,0.0849673150841575
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,33062,-0.000587417609633723,0.0242401165906884,-0.048098046127383,0.0469232109081156,0.980667055232626
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,33062,-0.00106102074689733,0.0114441994825802,-0.0234916517327546,0.0213696102389599,0.926133956567228
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,33058,-0.00850100223248422,0.0124991590055947,-0.0329993538834499,0.0159973494184814,0.496441840109632
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,33058,-0.0212353391950926,0.0176836789337131,-0.0558953499051703,0.013424671514985,0.229842655234281
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,33058,-0.00300283782373655,0.0287149502010988,-0.0592841402178903,0.0532784645704172,0.916716109481017
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,33058,0.0117622419129649,0.0282576870679306,-0.0436228247401791,0.0671473085661089,0.677237314078448
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,33058,0.026950291950287,0.0378262875441058,-0.0471892316361603,0.101089815536734,0.476188632717939
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,33058,0.010193041184029,0.0185330377160195,-0.0261317127393692,0.0465177951074273,0.582337522902482
APOA2,Apolipoprotein A-II,Mental health,X29171.Frequency of feeling 'in tune' with people,32900,-0.00497900519436353,0.0489932481939009,-0.101005771654409,0.0910477612656823,0.919055514252443
APOA2,Apolipoprotein A-II,Mental health,X29172.Freuency of feeling that lacks companionship,33017,0.0428961777370736,0.0448401669442468,-0.0449905494736501,0.130782904947797,0.338771092016957
APOA2,Apolipoprotein A-II,Mental health,X29173.Frequency of feeling left out,32972,-0.0225623488603601,0.0461266835017458,-0.112970648523782,0.0678459508030616,0.624755235329991
APOA2,Apolipoprotein A-II,Mental health,X29174.Frequency of feeling isolated from others,33001,-0.00772519063122259,0.0475577171026384,-0.100938316152394,0.0854879348899486,0.870964370801473
APOA2,Apolipoprotein A-II,Mental health,X29175.Tendency to bounce back quickly after hard times,33075,0.162736640221099,0.0402096988524828,0.0839256304702329,0.241547649971965,5.22580429255096e-05
APOA2,Apolipoprotein A-II,Mental health,X29176.Ability to make it through stressful events,33075,-0.0882376897905673,0.0392133704026531,-0.165095895779767,-0.0113794838013671,0.0244601321506251
APOA2,Apolipoprotein A-II,Mental health,X29177.Quick recovery from stressful events,33075,0.133474641037278,0.039954939369777,0.055162959872515,0.211786322202041,0.000839210130790549
APOA2,Apolipoprotein A-II,Mental health,X29178.Hard to snap back when something bad happens,33075,-0.079328543243091,0.0395746068345249,-0.15689477263876,-0.00176231384742226,0.0450423765342813
APOA2,Apolipoprotein A-II,Mental health,X29179.Comes through difficult times with little trouble,33075,0.1306604393066,0.0399384448860803,0.0523810873298823,0.208939791283317,0.00107354857043936
APOA2,Apolipoprotein A-II,Mental health,X29180.Tendency to take a long time to get over setbacks,33075,-0.0812548496235541,0.039781234651419,-0.159226069540335,-0.00328362970677275,0.0411261886210844
APOA2,Apolipoprotein A-II,Mental health,X29181.General happiness,33018,-0.127867897263002,0.0414065137921299,-0.209024664295576,-0.0467111302304271,0.00202036282184251
APOA2,Apolipoprotein A-II,Mental health,X29182.Belief that own life is meaningful,32932,0.0746705918902121,0.0411096257467527,-0.00590427457342327,0.155245458353847,0.069345510931666
APOA2,Apolipoprotein A-II,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28245,-0.0459210326328207,0.0558701289738919,-0.155426485421649,0.0635844201560074,0.411164516700436
APOA2,Apolipoprotein A-II,Health and medical history,X2946.Father's age,32687,0.00584980003959493,0.00773554988206305,-0.00931187772924864,0.0210114778084385,0.449535740317652
APOA2,Apolipoprotein A-II,Health and medical history,X2966.Age high blood pressure diagnosed,28405,-0.0505018733428837,0.0132287097801961,-0.0764301445120682,-0.0245736021736993,0.000136552098062688
APOA2,Apolipoprotein A-II,Blood and urine assays,X30000.White blood cell (leukocyte) count,47660,-0.0397632594644253,0.0033399954606916,-0.0463096505673808,-0.0332168683614697,1.37638459565623e-32
APOA2,Apolipoprotein A-II,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47660,-0.0376023994058383,0.00394411769860934,-0.0453328700951126,-0.029871928716564,1.65664864802726e-21
APOA2,Apolipoprotein A-II,Blood and urine assays,X30020.Haemoglobin concentration,47660,-0.0517688953441404,0.00419809660970581,-0.0599971646991638,-0.043540625989117,7.82998027111965e-35
APOA2,Apolipoprotein A-II,Blood and urine assays,X30030.Haematocrit percentage,47660,-0.0371715401872443,0.00412406736655556,-0.0452547122256932,-0.0290883681487954,2.1459076064156e-19
APOA2,Apolipoprotein A-II,Blood and urine assays,X30040.Mean corpuscular volume,47660,0.0103324813186027,0.00334185582871126,0.00378244389432862,0.0168825187428767,0.0019915035118528
APOA2,Apolipoprotein A-II,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47659,-0.00442121975594981,0.00334679063876064,-0.0109809294079207,0.00213848989602104,0.186503174076929
APOA2,Apolipoprotein A-II,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47659,-0.0295019999770105,0.0032710480697646,-0.0359132541937491,-0.0230907457602719,2.03553148331118e-19
APOA2,Apolipoprotein A-II,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47660,0.0398443749786562,0.00317863098080921,0.0336142582562702,0.0460744917010423,6.23337948767556e-36
APOA2,Apolipoprotein A-II,Blood and urine assays,X30080.Platelet count,47660,0.0129219913758333,0.00337273653369396,0.00631142776979317,0.0195325549818735,0.000127791226454109
APOA2,Apolipoprotein A-II,Blood and urine assays,X30090.Platelet crit,47660,0.0129065633631626,0.00345513469020901,0.00613449937035296,0.0196786273559723,0.0001877997035969
APOA2,Apolipoprotein A-II,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47660,-0.00327663062237642,0.00324782158808887,-0.00964236093503061,0.00308909969027776,0.313047114438669
APOA2,Apolipoprotein A-II,Blood and urine assays,X30110.Platelet distribution width,47660,-0.0105333420855359,0.00322147987295345,-0.0168474426365247,-0.00421924153454715,0.00107806273757229
APOA2,Apolipoprotein A-II,Blood and urine assays,X30120.Lymphocyte count,47627,-0.0589379438282452,0.0033864858985711,-0.0655754561894446,-0.0523004314670459,2.02067023763226e-67
APOA2,Apolipoprotein A-II,Blood and urine assays,X30130.Monocyte count,47627,-0.0343212400969109,0.00340314999776429,-0.0409914140925289,-0.0276510661012929,7.17933304512948e-24
APOA2,Apolipoprotein A-II,Blood and urine assays,X30140.Neutrophill count,47627,-0.0216079011012005,0.00331868782922883,-0.028112529246489,-0.015103272955912,7.61537283810067e-11
APOA2,Apolipoprotein A-II,Blood and urine assays,X30150.Eosinophill count,47627,-0.0128466561899099,0.00324462254004061,-0.0192061163683895,-0.00648719601143029,7.53669702950345e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30160.Basophill count,47627,-0.128500801493224,0.0268408425624899,-0.181108852915704,-0.0758927500707438,1.69879032484346e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30170.Nucleated red blood cell count,47627,0.204568369523618,0.119049905153912,-0.0287694445780499,0.437906183625285,0.0857474036535714
APOA2,Apolipoprotein A-II,Blood and urine assays,X30180.Lymphocyte percentage,47627,-0.0260195420455338,0.00334656485598531,-0.032578809163265,-0.0194602749278025,7.84977113639026e-15
APOA2,Apolipoprotein A-II,Blood and urine assays,X30190.Monocyte percentage,47627,-0.00470520690797896,0.00336125421331737,-0.011293265166081,0.00188285135012309,0.161575286276217
APOA2,Apolipoprotein A-II,Blood and urine assays,X30200.Neutrophill percentage,47627,0.0211694591539691,0.00329562231131956,0.0147100394237827,0.0276288788841554,1.35688314841681e-10
APOA2,Apolipoprotein A-II,Blood and urine assays,X30210.Eosinophill percentage,47627,0.000301952561923253,0.00320059764805658,-0.00597121882826765,0.00657512395211415,0.924837841365956
APOA2,Apolipoprotein A-II,Blood and urine assays,X30220.Basophill percentage,47627,-0.00331375823449636,0.00319784155714337,-0.00958152768649736,0.00295401121750464,0.300096809528102
APOA2,Apolipoprotein A-II,Blood and urine assays,X30230.Nucleated red blood cell percentage,47627,0.209476905698766,0.11993599844704,-0.0255976512574321,0.444551462654963,0.0807244551665425
APOA2,Apolipoprotein A-II,Blood and urine assays,X30240.Reticulocyte percentage,47225,-0.0204518394067953,0.00343857140015311,-0.0271914393510954,-0.0137122394624952,2.75683039879466e-09
APOA2,Apolipoprotein A-II,Blood and urine assays,X30250.Reticulocyte count,47225,-0.0280724837799412,0.00352709523554292,-0.0349855904416053,-0.0211593771182771,1.81135491498196e-15
APOA2,Apolipoprotein A-II,Blood and urine assays,X30260.Mean reticulocyte volume,47225,0.0430068279613333,0.00331103719451727,0.0365171950600795,0.0494964608625872,1.92138504617926e-38
APOA2,Apolipoprotein A-II,Blood and urine assays,X30270.Mean sphered cell volume,47225,0.0244534073806186,0.00333085577126613,0.017924930068937,0.0309818846923002,2.18154267656104e-13
APOA2,Apolipoprotein A-II,Blood and urine assays,X30280.Immature reticulocyte fraction,47225,0.0113495129563623,0.0034674503008495,0.00455331036669732,0.0181457155460274,0.00106507411848442
APOA2,Apolipoprotein A-II,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47225,-0.0115711210822417,0.00351660304546042,-0.0184636630513442,-0.00467857911313931,0.00100184026326021
APOA2,Apolipoprotein A-II,Blood and urine assays,X30300.High light scatter reticulocyte count,47225,-0.0175182603040775,0.00357781190791721,-0.0245307716435952,-0.0105057489645598,9.82788571244626e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30500.Microalbumin in urine,31003,0.0282822695389236,0.00624849544072849,0.0160352184750958,0.0405293206027515,6.10113140307926e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47766,-0.0220228619405446,0.00339713706239356,-0.028681250582836,-0.0153644732982532,9.18096523012747e-11
APOA2,Apolipoprotein A-II,Blood and urine assays,X30520.Potassium in urine,47716,-0.00969137039094786,0.00314722813238325,-0.015859937530419,-0.00352280325147669,0.00207698764502391
APOA2,Apolipoprotein A-II,Blood and urine assays,X30530.Sodium in urine,47715,-0.0194375328896724,0.00327926571378484,-0.0258648936886907,-0.0130101720906541,3.11991175462965e-09
APOA2,Apolipoprotein A-II,Blood and urine assays,X30600.Albumin,45308,0.00801062129932338,0.00354277699086887,0.00106677839722038,0.0149544642014264,0.0237621964660999
APOA2,Apolipoprotein A-II,Blood and urine assays,X30610.Alkaline phosphatase,47292,-0.0321718873954539,0.0033414691915824,-0.0387211670109554,-0.0256226077799524,6.6822944767201e-22
APOA2,Apolipoprotein A-II,Blood and urine assays,X30620.Alanine aminotransferase,47281,-0.0246052867996089,0.00354199893023156,-0.0315476047028627,-0.017662968896355,3.83655621398412e-12
APOA2,Apolipoprotein A-II,Blood and urine assays,X30630.Apolipoprotein A,45177,0.183575855473015,0.00365976960122804,0.176402707054608,0.190749003891422,0
APOA2,Apolipoprotein A-II,Blood and urine assays,X30640.Apolipoprotein B,47136,-0.0271933802541203,0.0033952456561851,-0.0338480617402431,-0.0205386987679975,1.20777918305921e-15
APOA2,Apolipoprotein A-II,Blood and urine assays,X30650.Aspartate aminotransferase,47214,0.0146737122815497,0.0033190905950651,0.00816829471522211,0.0211791298478773,9.86863087143712e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30660.Direct bilirubin,43589,0.0404516220492231,0.0036219189488568,0.0333526609094638,0.0475505831889825,7.09443413557318e-29
APOA2,Apolipoprotein A-II,Blood and urine assays,X30670.Urea,47286,-0.000454498648681782,0.00349843839507412,-0.00731143790302706,0.0064024406056635,0.896635012604547
APOA2,Apolipoprotein A-II,Blood and urine assays,X30680.Calcium,45305,0.0291088268298474,0.00344543280098982,0.0223557785399074,0.0358618751197875,3.13533014560732e-17
APOA2,Apolipoprotein A-II,Blood and urine assays,X30690.Cholesterol,47296,0.0141867905080561,0.00350246129136937,0.00732196637697211,0.02105161463914,5.12683358039055e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30700.Creatinine,47290,0.0723893304364583,0.00423395413868399,0.0640907803246377,0.0806878805482789,3.86104523805803e-65
APOA2,Apolipoprotein A-II,Blood and urine assays,X30710.C-reactive protein,47218,-0.0514758339243248,0.00361453951403994,-0.0585603313718431,-0.0443913364768066,7.89685184856487e-46
APOA2,Apolipoprotein A-II,Blood and urine assays,X30720.Cystatin C,47292,0.105867216845714,0.00386275385763178,0.098296219284756,0.113438214406673,8.30219167879736e-163
APOA2,Apolipoprotein A-II,Blood and urine assays,X30730.Gamma glutamyltransferase,47287,0.00548793258820843,0.00361362109383719,-0.00159476475571246,0.0125706299321293,0.128856661795353
APOA2,Apolipoprotein A-II,Blood and urine assays,X30740.Glucose,45273,-0.0137461063112994,0.00352176654812416,-0.0206487687456228,-0.00684344387697606,9.52257086642006e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47123,-0.0121566922831197,0.00350851049440758,-0.0190333728521586,-0.00528001171408087,0.00053135380569113
APOA2,Apolipoprotein A-II,Blood and urine assays,X30760.HDL cholesterol,45287,0.192240066061334,0.00388061272609874,0.18463406511818,0.199846067004487,0
APOA2,Apolipoprotein A-II,Blood and urine assays,X30770.IGF-1,47186,-0.0302074893947222,0.00343526616112303,-0.0369406110705233,-0.0234743677189211,1.55008189297035e-18
APOA2,Apolipoprotein A-II,Blood and urine assays,X30780.LDL direct,47245,-0.0169706377965853,0.00345964335919007,-0.0237515387805978,-0.0101897368125728,9.39041673387732e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30790.Lipoprotein A,42662,-0.00336556074793533,0.00362970079463361,-0.0104797743054172,0.00374865280954654,0.353819992804162
APOA2,Apolipoprotein A-II,Blood and urine assays,X30810.Phosphate,45254,0.0131293116343954,0.00345399845924104,0.00635947465428295,0.0198991486145078,0.000144400858425423
APOA2,Apolipoprotein A-II,Blood and urine assays,X30830.SHBG,45099,0.108772782158234,0.0039419122630896,0.101046634122578,0.116498930193889,1.05161943097909e-164
APOA2,Apolipoprotein A-II,Blood and urine assays,X30840.Total bilirubin,47207,0.0391637715706851,0.00337934249303905,0.0325402602843286,0.0457872828570417,5.68496223730949e-31
APOA2,Apolipoprotein A-II,Blood and urine assays,X30850.Testosterone,45400,0.0448141137161811,0.00570715973125189,0.0336280806429274,0.0560001467894348,4.276027407322e-15
APOA2,Apolipoprotein A-II,Blood and urine assays,X30860.Total protein,45292,0.0114053121126791,0.00351221483311902,0.00452137103976584,0.0182892531855924,0.00116673320366222
APOA2,Apolipoprotein A-II,Blood and urine assays,X30870.Triglycerides,47278,-0.081738277926665,0.00342967748602598,-0.0884604457992759,-0.0750161100540541,4.5993928791637e-124
APOA2,Apolipoprotein A-II,Blood and urine assays,X30880.Urate,47267,0.0134386594881597,0.00420663092057733,0.00519366288382812,0.0216836560924912,0.00140192268164099
APOA2,Apolipoprotein A-II,Blood and urine assays,X30890.Vitamin D,46335,0.0197860328102921,0.00362126809511854,0.0126883473438598,0.0268837182767245,4.70887437638501e-08
APOA2,Apolipoprotein A-II,Physical measures,X3137.Number of measurements made,46420,0.0234989833748175,0.0305112825698435,-0.0363031304620758,0.0833010972117107,0.441205005530989
APOA2,Apolipoprotein A-II,Physical measures,X3143.Ankle spacing width,37728,-0.00393646154004408,0.005928716449884,-0.0155567457818167,0.00768382270172856,0.506723607777784
APOA2,Apolipoprotein A-II,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37727,-0.00473899050334065,0.00453328185052721,-0.013624222930374,0.00414624192369267,0.295866788421787
APOA2,Apolipoprotein A-II,Physical measures,X3146.Speed of sound through heel,37728,-0.000454708263637168,0.00441703760838543,-0.00911210197607262,0.00820268544879828,0.918008771006892
APOA2,Apolipoprotein A-II,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37728,-0.00184713272437357,0.00445548500768894,-0.0105798833394439,0.00688561789069676,0.6784594605701
APOA2,Apolipoprotein A-II,Physical measures,X3148.Heel bone mineral density (BMD),37718,-0.00150927869555167,0.00446643504141779,-0.0102634913767305,0.00724493398562719,0.735431805422099
APOA2,Apolipoprotein A-II,Health and medical history,X3526.Mother's age at death,33842,-0.00980031165453273,0.0060055171579119,-0.02157112528404,0.00197050197497458,0.10273531858918
APOA2,Apolipoprotein A-II,Health and medical history,X3581.Age at menopause (last menstrual period),29542,-0.00922113679411396,0.00791082590117983,-0.0247263555604264,0.00628408197219852,0.243810906151185
APOA2,Apolipoprotein A-II,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29474,-0.00817784050379024,0.00761684940744517,-0.0231068653423828,0.00675118433480229,0.283025127537234
APOA2,Apolipoprotein A-II,Physical measures,X4100.Ankle spacing width (left),31721,0.00165748632556956,0.00787001536401604,-0.0137677437879019,0.017082716439041,0.833198813345393
APOA2,Apolipoprotein A-II,Physical measures,X4101.Heel broadband ultrasound attenuation (left),31721,-0.00251665382229919,0.00600498287253828,-0.0142864202524742,0.00925311260787584,0.675158700196837
APOA2,Apolipoprotein A-II,Physical measures,X4103.Speed of sound through heel (left),31721,-0.00225421394601653,0.00586677938256964,-0.013753101535853,0.00924467364381996,0.700815686619707
APOA2,Apolipoprotein A-II,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",31721,-0.00255504232853297,0.00591772325008062,-0.014153779898691,0.00904369524162505,0.665926941554112
APOA2,Apolipoprotein A-II,Physical measures,X4105.Heel bone mineral density (BMD) (left),31714,-0.00248555811843069,0.00593531712050359,-0.0141187796746177,0.00914766343775635,0.675392559168799
APOA2,Apolipoprotein A-II,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",31721,-0.00254124916045087,0.00591779786061767,-0.0141401329672615,0.00905763464635976,0.667625878298619
APOA2,Apolipoprotein A-II,Physical measures,X4119.Ankle spacing width (right),31711,0.00158454272055967,0.00773787747161529,-0.0135816971238063,0.0167507825649256,0.837751324105786
APOA2,Apolipoprotein A-II,Physical measures,X4120.Heel broadband ultrasound attenuation (right),31711,-0.0085126012760374,0.00607577834851519,-0.0204211268391272,0.00339592428705236,0.161232149790292
APOA2,Apolipoprotein A-II,Physical measures,X4122.Speed of sound through heel (right),31711,-0.00502863403957215,0.00590376780736148,-0.0166000189420007,0.00654275086285636,0.394369457647176
APOA2,Apolipoprotein A-II,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",31711,-0.00651829670457601,0.00596795985800387,-0.0182154980262636,0.00517890461711157,0.274772020146953
APOA2,Apolipoprotein A-II,Physical measures,X4124.Heel bone mineral density (BMD) (right),31703,-0.00754645038526617,0.00598575962040267,-0.0192785392412554,0.00418563847072306,0.207442220192942
APOA2,Apolipoprotein A-II,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",31711,-0.00651755355870333,0.00596800085422003,-0.0182148352329746,0.00517972811556794,0.274830037316295
APOA2,Apolipoprotein A-II,Physical measures,X4194.Pulse rate,31986,-0.0318516782800418,0.00571595001449954,-0.0430549403084609,-0.0206484162516227,2.59256044711222e-08
APOA2,Apolipoprotein A-II,Physical measures,X4195.Pulse wave reflection index,31986,0.00543087934341485,0.00558443706943039,-0.00551461731266871,0.0163763759994984,0.330829539008653
APOA2,Apolipoprotein A-II,Physical measures,X4196.Pulse wave peak to peak time,31981,0.0148926555598559,0.00597493024305855,0.00318179228346116,0.0266035188362507,0.0127036574534787
APOA2,Apolipoprotein A-II,Physical measures,X4198.Position of the pulse wave peak,31986,-0.0087535431146183,0.00574657974553236,-0.0200168394158617,0.00250975318662513,0.127732233021886
APOA2,Apolipoprotein A-II,Physical measures,X4199.Position of pulse wave notch,31986,-0.0248318526157954,0.00564543274029357,-0.0358969007867708,-0.01376680444482,1.10353428566747e-05
APOA2,Apolipoprotein A-II,Physical measures,X4200.Position of the shoulder on the pulse waveform,31986,-0.0193956855799971,0.00588243302244534,-0.03092525430399,-0.00786611685600422,0.000980656487425543
APOA2,Apolipoprotein A-II,Physical measures,X4269.Number of triplets attempted (left),31854,-0.0287268790339087,0.141392749440874,-0.305856667938022,0.248402909870204,0.83900670951284
APOA2,Apolipoprotein A-II,Physical measures,X4270.Volume level set by participant (left),31772,-0.00613300438070737,0.0420443808928959,-0.0885399909307833,0.0762739821693686,0.884027909799289
APOA2,Apolipoprotein A-II,Physical measures,X4276.Number of triplets attempted (right),31864,0.0756588184284968,0.140843725252236,-0.200394883065885,0.351712519922879,0.591156348258531
APOA2,Apolipoprotein A-II,Physical measures,X4277.Volume level set by participant (right),31774,-0.00932416780405754,0.0414607737211363,-0.0905872842974847,0.0719389486893696,0.822069636546599
APOA2,Apolipoprotein A-II,Cognitive function,X4288.Time to answer,32009,-0.00176016128228036,0.00651335062929149,-0.0145263285156917,0.011006005951131,0.786983243421058
APOA2,Apolipoprotein A-II,Cognitive function,X4290.Duration screen displayed,32009,0.00021532668863074,0.00570898979974835,-0.010974293318876,0.0114049466961375,0.969914144877442
APOA2,Apolipoprotein A-II,Physical measures,X46.Hand grip strength (left),48373,-0.00955913383624427,0.0045335038293401,-0.0184448013417509,-0.000673466330737673,0.0349932880332552
APOA2,Apolipoprotein A-II,Physical measures,X47.Hand grip strength (right),48353,-0.00785714214775496,0.00449865884540291,-0.0166745134847447,0.000960229189234751,0.0807275936557565
APOA2,Apolipoprotein A-II,Physical measures,X48.Waist circumference,48423,-0.0690917950513023,0.00709966817421216,-0.0830071446727582,-0.0551764454298465,2.42404503250056e-22
APOA2,Apolipoprotein A-II,Health and medical history,X4803.Tinnitus,31810,-0.0637622593360227,0.0514445989356891,-0.164593673249973,0.0370691545779279,0.215220882640294
APOA2,Apolipoprotein A-II,Working and living environment,X4825.Noisy workplace,31938,0.031005610892464,0.0554047440669863,-0.0775876874788291,0.139598909263757,0.575754081131852
APOA2,Apolipoprotein A-II,Working and living environment,X4836.Loud music exposure frequency,31886,0.0175362177263173,0.0604561949788612,-0.100957924432251,0.136030359884885,0.771774113697201
APOA2,Apolipoprotein A-II,Physical measures,X49.Hip circumference,48419,-0.00374192170616488,0.00562053911646501,-0.0147581783744363,0.00727433496210654,0.505571725846489
APOA2,Apolipoprotein A-II,Physical measures,X50.Standing height,48394,0.00163905052637017,0.00446391669944237,-0.00711022620453688,0.0103883272572772,0.713489662564027
APOA2,Apolipoprotein A-II,Health and medical history,X5057.Number of older siblings,31258,0.0226187943786123,0.0441825684817712,-0.0639790398456592,0.109216628602884,0.608708756328692
APOA2,Apolipoprotein A-II,Physical measures,X51.Seated height,48276,-0.0122737145505462,0.00413801236550051,-0.0203842187869272,-0.00416321031416521,0.00301904713555101
APOA2,Apolipoprotein A-II,Eye measures,X5181.Ever had eye surgery,29376,0.0703932254536618,0.110232705424844,-0.145662877179032,0.286449328086355,0.523117850953348
APOA2,Apolipoprotein A-II,Eye measures,X5186.Duration visual-acuity screen displayed (right),29366,0.00306017593713482,0.00707021262962929,-0.0107974408169386,0.0169177926912082,0.665157716124355
APOA2,Apolipoprotein A-II,Eye measures,X5188.Duration visual-acuity screen displayed (left),29364,0.00469913015187394,0.0070107641444894,-0.00904196757132528,0.0184402278750732,0.502711511475689
APOA2,Apolipoprotein A-II,Eye measures,X5190.Duration at which refractometer first shown (right),29313,0.00590829971658632,0.00692714001129997,-0.00766889470556161,0.0194854941387343,0.393740853847907
APOA2,Apolipoprotein A-II,Eye measures,X5193.Duration at which refractometer first shown (left),29311,0.0101769920327556,0.00695713051177899,-0.00345898377033118,0.0238129678358425,0.14357577237767
APOA2,Apolipoprotein A-II,Eye measures,"X5199.logMAR, initial (right)",29342,0.100199877956595,0.0515788111541834,-0.00089459190560448,0.201294347818795,0.0521089043440787
APOA2,Apolipoprotein A-II,Eye measures,X5200.Final number of letters displayed (right),29342,-0.471519213467867,0.382418803591593,-1.22106006850739,0.278021641571656,0.217631746908535
APOA2,Apolipoprotein A-II,Eye measures,"X5201.logMAR, final (right)",29296,0.0134676216018295,0.00665876495744668,0.000416442285234029,0.026518800918425,0.0431694166098852
APOA2,Apolipoprotein A-II,Eye measures,X5202.Number of rounds to result (right),29342,0.012962767408246,0.0497408522083372,-0.084529302920095,0.110454837736587,0.794406125500699
APOA2,Apolipoprotein A-II,Eye measures,"X5206.logMAR, initial (left)",29341,0.0543258918433755,0.0514391208048012,-0.0464947849340349,0.155146568620786,0.290959883144245
APOA2,Apolipoprotein A-II,Eye measures,X5207.Final number of letters displayed (left),29341,-0.738029112802435,0.346120408474424,-1.41642511341231,-0.0596331121925646,0.0330273505256931
APOA2,Apolipoprotein A-II,Eye measures,"X5208.logMAR, final (left)",29298,0.010600944438341,0.00669002998269486,-0.00251151432774095,0.0237134032044229,0.113118011154488
APOA2,Apolipoprotein A-II,Eye measures,X5209.Number of rounds to result (left),29337,-0.0281475512894948,0.0498518237884506,-0.125857125914858,0.0695620233358684,0.572352500046579
APOA2,Apolipoprotein A-II,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29130,0.00273421012893774,0.00693826494962341,-0.0108647891723242,0.0163332094301996,0.693540189724493
APOA2,Apolipoprotein A-II,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29130,0.00831072565618943,0.00682776565699516,-0.00507169503152108,0.0216931463438999,0.223584343005714
APOA2,Apolipoprotein A-II,Eye measures,X5256.Corneal hysteresis (right),29130,0.0041130019333632,0.00694795872252489,-0.00950499716278559,0.017731001029512,0.553894259048872
APOA2,Apolipoprotein A-II,Eye measures,X5257.Corneal resistance factor (right),29130,0.007589403684345,0.00681882652147209,-0.0057754962977403,0.0209543036664303,0.26575605940987
APOA2,Apolipoprotein A-II,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29108,-0.000698433114070122,0.00695501754840269,-0.0143302675089394,0.0129334012807991,0.920013558059233
APOA2,Apolipoprotein A-II,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29108,0.00212485327111497,0.00682005989194716,-0.0112424641171015,0.0154921706593314,0.755387824579983
APOA2,Apolipoprotein A-II,Eye measures,X5264.Corneal hysteresis (left),29108,0.00338580015975706,0.00691550859659474,-0.0101685966895686,0.0169401970090828,0.624440801784768
APOA2,Apolipoprotein A-II,Eye measures,X5265.Corneal resistance factor (left),29108,0.00491648543066435,0.00679957491173603,-0.00841068139633828,0.018243652257667,0.469676619234635
APOA2,Apolipoprotein A-II,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29175,0.0314812053867916,0.212285110239331,-0.384597610682298,0.447560021455881,0.882114156747658
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48345,0.0645628683739188,0.0191423213384134,0.0270439185506285,0.102081818197209,0.000745281885423352
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48345,0.0632735104326833,0.021244438733739,0.021634410514555,0.104912610350812,0.0029008268651205
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48345,0.0331561712653662,0.0526756031169175,-0.070088010843792,0.136400353374524,0.529066418062908
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48345,-0.000731244675249824,0.00889259288847602,-0.0181607267366628,0.0166982373861632,0.934463885154555
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48345,-0.021648291256348,0.00798373648773112,-0.037296414772301,-0.00600016774039501,0.0067016398879785
APOA2,Apolipoprotein A-II,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",36076,-0.019930912824923,0.00926603526550733,-0.0380923419453173,-0.00176948370452861,0.0314985550404119
APOA2,Apolipoprotein A-II,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",36076,0.0229444855923692,0.0322803743306522,-0.0403250480957091,0.0862140192804475,0.477229516444401
APOA2,Apolipoprotein A-II,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",36076,-0.00264351212004647,0.0158584405181812,-0.0337260555356815,0.0284390312955886,0.867613325874352
APOA2,Apolipoprotein A-II,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",36076,0.00870896888235573,0.0100124492142102,-0.0109154315774962,0.0283333693422077,0.384419128765777
APOA2,Apolipoprotein A-II,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48413,0.0281957101578477,0.0178973093973982,-0.00688301626105282,0.0632744365767482,0.115173304190931
APOA2,Apolipoprotein A-II,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48413,0.0281957101578477,0.0178973093973982,-0.00688301626105282,0.0632744365767482,0.115173304190931
APOA2,Apolipoprotein A-II,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48413,-0.0188503062990087,0.0132077861760129,-0.044737567203994,0.00703695460597664,0.153531614408338
APOA2,Apolipoprotein A-II,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48413,-0.0238947711378063,0.0205839082493996,-0.0642392313066295,0.0164496890310169,0.245715352408589
APOA2,Apolipoprotein A-II,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48413,0.0020550200561149,0.0514657096210854,-0.0988177708012124,0.102927810913442,0.968149347027307
APOA2,Apolipoprotein A-II,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48413,0.0724709123116676,0.036589761866626,0.000754979053080682,0.144186845570254,0.0476435183079515
APOA2,Apolipoprotein A-II,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48413,0.0721825398322618,0.0538612175812226,-0.0333854466269345,0.177750526291458,0.180206395097764
APOA2,Apolipoprotein A-II,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48344,0.0160270474956126,0.0102283251811505,-0.00402046985944232,0.0360745648506675,0.117144482366751
APOA2,Apolipoprotein A-II,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48344,0.00411680728310883,0.0175175547487979,-0.030217600024535,0.0384512145907527,0.814202638320177
APOA2,Apolipoprotein A-II,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48344,-0.00600584651672917,0.00857416828055704,-0.022811216346621,0.0107995233131626,0.483647854107448
APOA2,Apolipoprotein A-II,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48344,0.0131009809223524,0.0160167913410186,-0.018291930106044,0.0444938919507488,0.413392042294498
APOA2,Apolipoprotein A-II,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48344,0.00392119253718762,0.01398806202608,-0.0234954090339292,0.0313377941083044,0.779231141036345
APOA2,Apolipoprotein A-II,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48344,0.0221610004780035,0.0113004612496022,1.20964287831822e-05,0.0443099045272238,0.0498821245246071
APOA2,Apolipoprotein A-II,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29320,0.12141620121381,0.0320285065101957,0.0586403284538269,0.184192073973794,0.000151733524904815
APOA2,Apolipoprotein A-II,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29320,0.0412591085691088,0.0281570782837076,-0.0139287648669581,0.0964469820051756,0.142891419445172
APOA2,Apolipoprotein A-II,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29320,0.0673428019881398,0.0343099111737892,9.53760875130744e-05,0.134590227888767,0.0497224597275454
APOA2,Apolipoprotein A-II,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29320,-0.0342434566240777,0.028538180361887,-0.0901782901333763,0.0216913768852209,0.230223518611266
APOA2,Apolipoprotein A-II,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48303,0.0586909681507314,0.0281545717409935,0.00350800753838409,0.113873928763079,0.0371161470995705
APOA2,Apolipoprotein A-II,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48303,0.0623725928037057,0.0410290774704145,-0.0180443990383067,0.142789584645718,0.128472493243739
APOA2,Apolipoprotein A-II,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48303,0.0203935684788181,0.0847892323328949,-0.145793326893656,0.186580463851292,0.809928607938218
APOA2,Apolipoprotein A-II,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48303,0.139470720916852,0.069223014911872,0.00379361168958325,0.275147830144122,0.0439362494918428
APOA2,Apolipoprotein A-II,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48303,0.0772564543754849,0.0259762436400411,0.0263430168410044,0.128169891909965,0.00294117424788753
APOA2,Apolipoprotein A-II,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48303,0.0304394682407605,0.0333038084611627,-0.0348359963431183,0.0957149328246394,0.360729217008715
APOA2,Apolipoprotein A-II,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48303,0.0159993306499131,0.0136090484198292,-0.0106744042529522,0.0426730655527783,0.239750539130808
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32338,0.0768644095344861,0.0260352702327868,0.025835279878224,0.127893539190748,0.00316262130118867
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32338,0.0291100403819853,0.0291693112557034,-0.0280618096791935,0.086281890443164,0.318323338716103
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32338,0.13548532737557,0.0372655525051,0.0624448444655735,0.208525810285566,0.000278899674165904
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32338,0.0132679041594027,0.0113471710077567,-0.00897255101580042,0.0355083593346059,0.242327827264829
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",34228,0.0248700195680785,0.0128007627821362,-0.000219475484908499,0.0499595146210654,0.0520607755841168
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",34228,-0.0315418849398124,0.0103633924323702,-0.051854134107258,-0.0112296357723668,0.00234361591092722
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",34228,0.00278306312489999,0.0102441034103552,-0.0172953795593961,0.0228615058091961,0.785877610194958
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",34229,0.00494144437056375,0.0247965957746568,-0.0436598833477635,0.053542772088891,0.842048300373245
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",34229,0.0196077923138322,0.01615378673447,-0.012053629685729,0.0512692143133934,0.22484404505395
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",34229,0.0749823845037869,0.0203356264005881,0.0351245567586342,0.11484021224894,0.000227854883923842
APOA2,Apolipoprotein A-II,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48344,0.0255703664760597,0.0238551534960481,-0.0211857343761947,0.072326467328314,0.283774998759546
APOA2,Apolipoprotein A-II,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48344,0.0175051566550391,0.0153774396138111,-0.0126346249880307,0.0476449382981089,0.254978763055924
APOA2,Apolipoprotein A-II,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48344,-0.0506529732698819,0.0478411764186924,-0.144421679050519,0.0431157325107552,0.289713357189858
APOA2,Apolipoprotein A-II,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48344,0.0443318716550646,0.0174247446845073,0.0101793720734303,0.0784843712366988,0.0109592184002159
APOA2,Apolipoprotein A-II,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48344,0.00362511329228533,0.0192460725025293,-0.034097188812672,0.0413474153972427,0.850599147792696
APOA2,Apolipoprotein A-II,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48344,0.045605862257036,0.0211037506757433,0.00424251093257915,0.0869692135814928,0.0307025988440637
APOA2,Apolipoprotein A-II,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48344,-0.0133147569252658,0.00685737187767103,-0.026755205805501,0.000125691954969384,0.0521884541017061
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27579,0.0785923219898967,0.0230963177118466,0.0333235392746774,0.123861104705116,0.000674019354933702
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27579,-0.00634257840215491,0.0295666495929771,-0.0642932116043901,0.0516080548000803,0.830154896389302
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27579,-0.0721599659217071,0.0217211286086441,-0.114733377994649,-0.0295865538487648,0.000902028285413925
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27579,0.0162826440165463,0.0182147465988424,-0.0194182593171848,0.0519835473502773,0.371419081893405
APOA2,Apolipoprotein A-II,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48460,-0.00359664510978084,0.00735025493227719,-0.0180031447770441,0.0108098545574825,0.624617757877963
APOA2,Apolipoprotein A-II,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48460,0.0376394480224391,0.0215168916439266,-0.00453365959965714,0.0798125556445353,0.0802520515131765
APOA2,Apolipoprotein A-II,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48460,-0.00278817474303786,0.00740473341926416,-0.0173014522447956,0.0117251027587199,0.706519090781599
APOA2,Apolipoprotein A-II,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48460,0.0128661245398369,0.00720666928277439,-0.00125894725440094,0.0269911963340747,0.0742236833058834
APOA2,Apolipoprotein A-II,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48460,0.013571042796697,0.0104562692807763,-0.00692324499362443,0.0340653305870185,0.194338769798744
APOA2,Apolipoprotein A-II,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48460,0.014282787723712,0.0106545112102464,-0.00660005424837097,0.035165629695795,0.180082555578397
APOA2,Apolipoprotein A-II,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48460,0.0272468179215206,0.00794693407104683,0.0116708271422688,0.0428228087007724,0.000607708212158066
APOA2,Apolipoprotein A-II,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48460,0.0533649646647926,0.0223459985141125,0.00956680757713203,0.0971631217524531,0.0169422285552928
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,40493,0.0215484135967421,0.00785266068407236,0.00615719865596022,0.0369396285375239,0.00607438086381631
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,40493,0.0205159120014227,0.0082467418229849,0.00435229802837231,0.0366795259744731,0.0128647727590291
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,40493,-0.0152703849027376,0.00984960448519407,-0.0345756096937179,0.00403483988824282,0.121075326044531
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,40494,-0.0197737425758865,0.0135123512827247,-0.0462579510900269,0.00671046593825379,0.143381555242716
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,40494,-0.0139548360702361,0.00872595354810225,-0.0310577050245165,0.00314803288404432,0.109787751268346
APOA2,Apolipoprotein A-II,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48252,-0.033420874788918,0.00813093069707565,-0.0493574989551862,-0.0174842506226497,3.96371535233563e-05
APOA2,Apolipoprotein A-II,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48252,0.0130382090149751,0.00638848226680101,0.000516783772045113,0.0255596342579051,0.0412722013968424
APOA2,Apolipoprotein A-II,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48252,0.0204289178507943,0.00761973086470463,0.00549424535597322,0.0353635903456154,0.00734397968731495
APOA2,Apolipoprotein A-II,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48252,0.0381288717054839,0.0118647357466342,0.0148739896420808,0.061383753768887,0.00131238767347332
APOA2,Apolipoprotein A-II,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48267,-0.00734257799487781,0.00699194574611658,-0.0210467916572663,0.00636163566751068,0.293660460586765
APOA2,Apolipoprotein A-II,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48267,0.03006523914059,0.00966963550265134,0.0111127535553933,0.0490177247257866,0.00187783627112851
APOA2,Apolipoprotein A-II,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48344,0.0166707297827516,0.00740649298358552,0.00215400353492398,0.0311874560305792,0.0244053702393417
APOA2,Apolipoprotein A-II,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48344,-0.000295520566588001,0.0091516561945266,-0.0182327667078601,0.0176417255746841,0.974239863052017
APOA2,Apolipoprotein A-II,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48344,0.0596624855581454,0.0135868884226944,0.0330321842496643,0.0862927868666265,1.13209005450393e-05
APOA2,Apolipoprotein A-II,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48344,0.00465015980597143,0.0160891966375301,-0.0268846656035877,0.0361849852155305,0.772565656598163
APOA2,Apolipoprotein A-II,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48344,0.034620027701478,0.0156060422391312,0.00403218491278085,0.0652078704901752,0.0265385266121332
APOA2,Apolipoprotein A-II,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48344,-0.0231795836313137,0.022826425474478,-0.0679193775612905,0.0215602102986632,0.309891178183976
APOA2,Apolipoprotein A-II,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37728,-0.00184934336978603,0.004455505009134,-0.0105821331876887,0.00688344644811662,0.678097589649903
APOA2,Apolipoprotein A-II,Physical activities,X864.Number of days or week walked 10+ minutes,48003,0.0704331311339075,0.0239346419163359,0.0235212329778891,0.117345029289926,0.00325644007198758
APOA2,Apolipoprotein A-II,Physical activities,X874.Duration of walks,44809,0.00604063777943628,0.0033031554077682,-0.000433546819789395,0.012514822378662,0.0674516262433747
APOA2,Apolipoprotein A-II,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47352,0.0978827692218084,0.0232737064916093,0.0522663044982543,0.143499233945363,2.6121265448587e-05
APOA2,Apolipoprotein A-II,Physical activities,X894.Duration of moderate activity,42036,0.0557703276117692,0.0279484202180575,0.000991423984376551,0.110549231239162,0.0460061787340215
APOA2,Apolipoprotein A-II,Physical activities,X90087.No-wear time bias adjusted average acceleration,29265,0.00769092410636925,0.0067014065737551,-0.00544383277819075,0.0208256809909293,0.251160493867421
APOA2,Apolipoprotein A-II,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47367,0.11629766283481,0.0239257944991444,0.0694031056164867,0.163192220053133,1.1768722055404e-06
APOA2,Apolipoprotein A-II,Physical activities,X914.Duration of vigorous activity,37687,0.0121754252426047,0.00418621963666341,0.00397043475474437,0.020380415730465,0.00363799219239614
